HDL levels are inversely related to the risk of developing atherosclerosis. In serum, paraoxonase (PON) is associated with HDL, and was shown to inhibit LDL oxidation. Whether PON also protects HDL from oxidation is unknown, and was determined in the present study. In humans, we found serum HDL PON activity and HDL susceptibility to oxidation to be inversely correlated (r2 = 0.77, n = 15). Supplementing human HDL with purified PON inhibited copper-induced HDL oxidation in a concentration-dependent manner. Adding PON to HDL prolonged the oxidation lag phase and reduced HDL peroxide and aldehyde formation by up to 95%. This inhibitory effect was most pronounced when PON was added before oxidation initiation. When purified PON was added to whole serum, essentially all of it became HDL-associated. The PON-enriched HDL was more resistant to copper ion-induced oxidation than was control HDL. Compared with control HDL, HDL from PON-treated serum showed a 66% prolongation in the lag phase of its oxidation, and up to a 40% reduction in peroxide and aldehyde content. In contrast, in the presence of various PON inhibitors, HDL oxidation induced by either copper ions or by a free radical generating system was markedly enhanced. As PON inhibited HDL oxidation, two major functions of HDL were assessed: macrophage cholesterol efflux, and LDL protection from oxidation. Compared with oxidized untreated HDL, oxidized PON-treated HDL caused a 45% increase in cellular cholesterol efflux from J-774 A.1 macrophages. Both HDL-associated PON and purified PON were potent inhibitors of LDL oxidation. Searching for a possible mechanism for PON-induced inhibition of HDL oxidation revealed PON (2 paraoxonase U/ml)-mediated hydrolysis of lipid peroxides (by 19%) and of cholesteryl linoleate hydroperoxides (by 90%) in oxidized HDL. HDL-associated PON, as well as purified PON, were also able to substantially hydrolyze (up to 25%) hydrogen peroxide (H2O2), a major reactive oxygen species produced under oxidative stress during atherogenesis. Finally, we analyzed serum PON activity in the atherosclerotic apolipoprotein E-deficient mice during aging and development of atherosclerotic lesions. With age, serum lipid peroxidation and lesion size increased, whereas serum PON activity decreased. We thus conclude that HDL-associated PON possesses peroxidase-like activity that can contribute to the protective effect of PON against lipoprotein oxidation. The presence of PON in HDL may thus be a major contributor to the antiatherogenicity of this lipoprotein.
M Aviram, M Rosenblat, C L Bisgaier, R S Newton, S L Primo-Parmo, B N La Du
Title and authors | Publication | Year |
---|---|---|
Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice
Kim YJ, Park S, Kim H, Kim SR, Jung UJ |
Nutrients | 2025 |
High-density lipoprotein cholesterol: how studying the ‘good cholesterol’ could improve cardiovascular health
Diaz L, Bielczyk-Maczynska E |
Open Biology | 2025 |
The interaction between a leflunomide-response methylation site (cg17330251) and variant (rs705379) on response to leflunomide in patients with rheumatoid arthritis
Zhao F, Chen Y, Liu H, Jin L, Feng X, Dai B, Chen M, Wang Q, Yao Y, Liao R, Zhao J, Qu B, Song Y, Fu L |
Frontiers in Pharmacology | 2025 |
Investigating the role of the Pon1-rs854560 (L55M) SNP in colorectal Cancer susceptibility.
Wei X, Qin R, Yin L, Iqbal MA, Shaibu Z, Li G, Wu T |
Journal of cancer research and clinical oncology | 2025 |
Effect of fentanyl and remifentanil on neuron damage and oxidative stress during induction neurotoxicity.
Taghizadehghalehjoughi A, Naldan ME, Yeni Y, Genc S, Hacimuftuoglu A, Isik M, Necip A, Bolat İ, Yildirim S, Beydemir S, Baykan M |
Journal of Cellular and Molecular Medicine | 2024 |
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis
Durrington P, Soran H |
Current Opinion in Lipidology | 2024 |
Dysfunctional HDL Diagnostic Metrics for Cardiovascular Disease Risk Stratification: Are we Ready to Implement in Clinics?
Kempegowda SN, Sugur K, Thimmulappa RK |
Journal of cardiovascular translational research | 2024 |
Exploring the Relationship between Canine Paraoxonase-1 (PON-1) Serum Activity and Liver Disease Classified by Clinico-Pathological Evaluation.
Meazzi S, Bristi SZT, Bianchini V, Scarpa P, Giordano A |
Animals : an open access journal from MDPI | 2024 |
The Molecular Bases of Anti-Oxidative and Anti-Inflammatory Properties of Paraoxonase 1
Jakubowski H |
Antioxidants | 2024 |
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions—A Comprehensive Review
Lewoń-Mrozek D, Kurzynoga J, Jędrzejewski P, Kędzierska K, Partyka A, Kuriata-Kordek M, Ściskalska M |
International Journal of Molecular Sciences | 2024 |
Allostatic Load and Oxidative Stress Markers in Women With Early- and Late-Onset Preeclampsia
Montoya-Estrada A, García-Cerda MV, Guzmán-Grenfell AM, Figueroa-Damian R, Torres-Cosme JL, Laresgoiti-Servitje E, Beltrán-Montoya JJ, Romo-Yañez J, Reyes-Muñoz E |
Cureus | 2024 |
Highly Dynamic Gene Family Evolution Suggests Changing Roles for PON Genes Within Metazoa
Lucas SA, Graham AM, Presnell JS, Clark NL |
Genome Biology and Evolution | 2023 |
Paraoxonase 1 and atherosclerosis
Durrington PN, Bashir B, Soran H |
Frontiers in Cardiovascular Medicine | 2023 |
Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D, Ściskalska M, Kepinska M |
International journal of environmental research and public health | 2023 |
Biological Health Markers Associated with Oxidative Stress in Dairy Cows during Lactation Period.
Tufarelli V, Colonna MA, Losacco C, Puvača N |
Metabolites | 2023 |
Paraoxonases at the Heart of Neurological Disorders.
Khalaf FK, Connolly J, Khatib-Shahidi B, Albehadili A, Tassavvor I, Ranabothu M, Eid N, Dube P, Khouri SJ, Malhotra D, Haller ST, Kennedy DJ |
International journal of molecular sciences | 2023 |
Proteomic Exploration of Paraoxonase 1 Function in Health and Disease
Jakubowski H |
International journal of molecular sciences | 2023 |
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.
Sulaiman D, Choi LS, Lee HM, Shin J, Kim DH, Lee KW, Eftekhari P, Quartier A, Park HS, Reddy ST |
Biomolecules | 2023 |
The effects of dietary essential fatty acid ratios and energy level on growth performance, lipid metabolism, and inflammation in grow-finish pigs.
Becker SL, Humphrey DC, Karriker LA, Brown JT, Skoland KJ, Greiner LL |
Journal of animal science | 2023 |
Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study.
Huang C, Zhang J, Huang J, Li H, Wen K, Bao J, Wu X, Sun R, Abudukeremu A, Wang Y, He Z, Chen Q, Huang X, Wang H, Zhang Y |
Lipids in Health and Disease | 2023 |
Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects
Bacchetti T, Morresi C, Ferretti G, Larsson A, Åkerfeldt T, Svensson M |
Metabolites | 2023 |
Echinacea purpurea extract intervention for counteracting neurochemical and behavioral changes induced by bifenthrin.
Abdel-Wahhab KG, Sayed RS, El-Sahra DG, Hassan LK, Elqattan GM, Mannaa FA |
Metabolic Brain Disease | 2023 |
CRP/HDL-C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.
Djesevic M, Hasic S, Lepara O, Jahic R, Kurtovic A, Fajkic A |
2023 | |
HDL Metabolism and Diseases
L Zheng |
2022 | |
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang, Junnan Tang |
Aging and disease | 2022 |
HDL Composition, Heart Failure, and Its Comorbidities
A Diab, C Ripoll, Z Guo, A Javaheri |
Frontiers in Cardiovascular Medicine | 2022 |
HDL and Endothelial Function.
Wu Y, Xu Y, Chen J, Zhao M, Rye KA |
Advances in experimental medicine and biology | 2022 |
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.
Vyletelová V, Nováková M, Pašková Ľ |
Pharmaceuticals (Basel, Switzerland) | 2022 |
Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS, Shahbazian A, Wang J, Golub I, Oganesian B, Dowd T, Vayngortin B, Wang R, Elashoff D, Reddy ST, Charles-Schoeman C |
Rheumatology (Oxford, England) | 2022 |
Sensitive Assay for the Lactonase Activity of Serum Paraoxonase 1 (PON1) by Harnessing the Fluorescence Turn-On Characteristics of Bioorthogonally Synthesized and Geometrically Controlled Chemical Probes.
Fang BK, Dai CY, Severance S, Hwang CC, Huang CH, Hou SY, Yeh BL, Gong MM, Chou YH, Wang JJ, Wang TP |
Molecules (Basel, Switzerland) | 2022 |
The Hydrolysis Rate of Paraoxonase-1 Q and R Isoenzymes: An In Silico Study Based on In Vitro Data.
Karabulut S, Mansour B, Casanola-Martin GM, Rasulev B, Gauld JW |
Molecules (Basel, Switzerland) | 2022 |
Ameliorations in dyslipidemia and atherosclerotic plaque by the inhibition of HMG-CoA reductase and antioxidant potential of phytoconstituents of an aqueous seed extract of Acacia senegal (L.) Willd in rabbits.
Charan J, Riyad P, Ram H, Purohit A, Ambwani S, Kashyap P, Singh G, Hashem A, Abd Allah EF, Gupta VK, Kumar A, Panwar A |
PloS one | 2022 |
Effect of Carotenoids on Paraoxonase-1 Activity and Gene Expression.
Otocka-Kmiecik A |
Nutrients | 2022 |
Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
Meszaros M, Bikov A |
Biomedicines | 2022 |
Paraoxonase 1 and atrial fibrillation: Is there a relationship?
Istratoaie S, Boroş B, Vesa ŞC, Maria Pop R, Cismaru G, Pop D, Vasile Milaciu M, Ciumărnean L, Văcăraş V, Dana Buzoianu A |
Medicine | 2022 |
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct
Holzer M, Ljubojevic-Holzer S, Souza Junior DR, Stadler JT, Rani A, Scharnagl H, Ronsein GE, Marsche G |
Journal of lipid research | 2022 |
Periconceptional Mediterranean diet during pregnancy on children's health.
Çobanoğullari H, Ergoren MC, Dundar M, Bertelli M, Tulay P |
Journal of Preventive Medicine and Hygiene | 2022 |
Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Erre GL, Bassu S, Giordo R, Mangoni AA, Carru C, Pintus G, Zinellu A |
2022 | |
Effect of Dialyzer Reuse on the Activity of Paraoxonase 1 in Patients on Hemodialysis.
Miguita R Jr, Matsumoto AK, Michelin AP, Morelli NR, Baltus THL, Delfino VDA, Barbosa DS |
Indian journal of nephrology | 2022 |
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
I Schilcher, JT Stadler, M Lechleitner, A Hrzenjak, A Berghold, G Pregartner, M Lhomme, M Holzer, M Korbelius, F Reichmann, A Springer, C Wadsack, T Madl, D Kratky, A Kontush, G Marsche, S Frank |
International journal of molecular sciences | 2021 |
High density lipoproteins and oxidative stress in breast cancer
G Mazzuferi, T Bacchetti, O Islam, G Ferretti |
Lipids in Health and Disease | 2021 |
Paraoxonase‐1 (PON1) Status Analysis Using Non‐Organophosphate Substrates
J Marsillach, RJ Richter, LG Costa, CE Furlong |
2021 | |
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
SA Dabravolski, EE Bezsonov, MS Baig, TV Popkova, LV Nedosugova, AV Starodubova, AN Orekhov |
International journal of molecular sciences | 2021 |
Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality.
Stadler JT, Marsche G |
Frontiers in Nutrition | 2021 |
The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases
A Wysocka, A Zwolak |
International journal of molecular sciences | 2021 |
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
AE Grzegorzewska, P Adamska, E Iwańczyk-Skalska, K Ostromecka, L Niepolski, W Marcinkowski, A Mostowska, W Warchoł, C Żaba, PP Jagodziński |
Scientific Reports | 2021 |
Anabolic treatments in bovines: quantification of plasma protein markers of dexamethasone administration
R Stella, D Bovo, E Mastrorilli, M Pezzolato, E Bozzetta, G Biancotto |
PROTEOMICS | 2021 |
Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis
AE Grzegorzewska, K Ostromecka, MK Świderska, P Adamska, A Mostowska, PP Jagodziński |
Scientific Reports | 2021 |
EPA’s pleiotropic mechanisms of action: a narrative review
JR Nelson, MJ Budoff, OR Wani, V Le, DK Patel, A Nelson, RL Nemiroff |
Postgraduate Medicine | 2021 |
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
AE Grzegorzewska, A Mostowska, W Warchoł, PP Jagodziński |
BMC Infectious Diseases | 2021 |
The effect of grape products containing polyphenols on oxidative stress: a systematic review and meta-analysis of randomized clinical trials
S Sarkhosh-Khorasani, ZS Sangsefidi, M Hosseinzadeh |
Nutrition Journal | 2021 |
The Role of Oxidative Stress in Sarcoidosis
SS Fois, S Canu, AG Fois |
International journal of molecular sciences | 2021 |
Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
XJ Zhao, LC Liu, C Guo, WW Shen, J Cao, F Du, DF Wu, H Yu |
Annals of translational medicine | 2021 |
Serum Paroxonase 1 level may be an Indicator and Predictor of the Severity of Androgenetic Alopecia.
Tantawy M, Khabir AA, Mahsoub N, Zohdy M |
International journal of trichology | 2021 |
Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia.
Riva A, Petrangolini G, Allegrini P, Perna S, Giacosa A, Peroni G, Faliva MA, Naso M, Rondanelli M |
Nutrients | 2021 |
Repetitions of Strenuous Exercise Consistently Increase Paraoxonase 1 Concentration and Activity in Plasma of Average-Trained Men.
Otocka-Kmiecik A, Orłowska-Majdak M, Stawski R, Szkudlarek U, Kosielski P, Padula G, Gałczyński S, Nowak D |
Oxidative medicine and cellular longevity | 2021 |
PON1 (Paraoxonase 1) Q192R Gene Polymorphism in Ischemic Stroke among North Indian Population.
Gupta A, Saluja A, Saraswathy KN, Imnameren L, Yadav S, Dhamija RK |
Annals of Indian Academy of Neurology | 2021 |
Association Between PON1 (L55M and Q192R) Genetic Polymorphism and Recurrent Pregnancy Loss in North Indian Women Exposed to Pesticides.
Jaiswar SP, Priyadarshini A, Singh A, Ahmad MK, Deo S, Sankhwar P |
2021 | |
Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?
AM Fernández-Ortiz, AM Ortiz, S Pérez, E Toledano, L Abásolo, MA González-Gay, S Castañeda, I González-Álvaro |
Arthritis Research & Therapy | 2020 |
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
J Marsillach, MP Adorni, F Zimetti, B Papotti, G Zuliani, C Cervellati |
Antioxidants | 2020 |
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
A Taler-Verčič, M Goličnik, A Bavec |
Molecules (Basel, Switzerland) | 2020 |
Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease
N Decharatchakul, C Settasatian, N Settasatian, N Komanasin, U Kukongviriyapan, P Intharapetch, V Senthong, K Sawanyawisuth |
Heart and Vessels | 2020 |
Biological Activities of Egg Yolk Lipids: A Review
N Xiao, Y Zhao, Y Yao, N Wu, M Xu, H Du, Y Tu |
Journal of Agricultural and Food Chemistry | 2020 |
African Walnuts (Tetracarpidium conophorum) Modulate Hepatic Lipid Accumulation in Obesity via Reciprocal Actions on HMG-CoA Reductase and Paraoxonase
DE Uti, IJ Atangwho, EU Eyong, GU Umoru, GE Egbung, SO Rotimi, VU Nna |
Endocrine, metabolic & immune disorders drug targets | 2020 |
Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies
M Işık, Ş Beydemir, Y Demir, M Durgun, C Türkeş, A Nasır, A Necip, M Akkuş |
International Journal of Biological Macromolecules | 2020 |
Metabolome and proteome changes in skeletal muscle and blood of pre-weaning calves fed leucine and threonine supplemented diets
K Yu, M Matzapetakis, A Horvatić, M Terré, A Bach, J Kuleš, N Yeste, N Gómez, L Arroyo, E Rodríguez-Tomàs, R Peña, N Guillemin, AM de Almeida, PD Eckersall, A Bassols |
Journal of Proteomics | 2020 |
Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
M Wiciński, K Górski, E Wódkiewicz, M Walczak, M Nowaczewska, B Malinowski |
International journal of molecular sciences | 2020 |
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study
S Bassu, A Zinellu, S Sotgia, AA Mangoni, A Floris, G Farina, G Passiu, C Carru, GL Erre |
Molecules (Basel, Switzerland) | 2020 |
Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia
D Scavone, M Sgorbini, AS Borges, JP Oliveira-Filho, V Vitale, S Paltrinieri |
BMC veterinary research | 2020 |
Effect of Roux-en-Y Gastric Bypass on Lipoprotein Metabolism and Markers of HDL Functionality in Morbid Obese Patients
EL Chiappe, M Martin, AI Molli, A Millan, W Tetzlaff, E Botta, F Ferraro, MS Sáez, MV Gonzalez, L Boero, P Sorroche, A Beskow, M Gutierrez, G Cerrone, S Gutt, G Frechtel, F Brites |
Obesity Surgery | 2020 |
Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses
G Rossi, A Richardson, H Jamaludin, C Secombe |
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc | 2020 |
Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis
A Kunjantarachot, N Pabalan, H Jarjanazi, DM Christofolini, E Montagna, CP Barbosa, B Bianco |
Reproductive Biology and Endocrinology | 2020 |
High-Density Lipoprotein-Targeted Therapies for Heart Failure
M Mishra, BD Geest |
Biomedicines | 2020 |
The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial
M Tabatabaie, S Abdollahi, A SalehiAbargouei, CC Clark, E KarimiNazari, H Fallahzadeh, M Rahmanian, H MozaffariKhosravi |
Phytotherapy research : PTR | 2020 |
Baicalein maintains redox balance in experimental hyperlipidemic rats
SS Tripathi, R Kumar, A Bissoyi, SI Rizvi |
Archives Of Physiology And Biochemistry | 2020 |
Handbook of Dietary Phytochemicals
J Xiao, SD Sarker, Y Asakawa |
2020 | |
ABCA1 gene R1587K polymorphism could be associated with metabolic syndrome and increased plasma triglyceride concentration in adults from northern Mexico
MP Quijada, ZR Castillo, OR Pellegrini, EA Ochoa, SY Camarena, MM Corral, MN Vásquez |
Nutrición hospitalaria | 2020 |
Paraoxonase 1 gene polymorphisms concerning non-insulin-dependent diabetes mellitus nephropathy in hemodialysis patients
AE Grzegorzewska, K Ostromecka, P Adamska, A Mostowska, W Warchoł, PP Jagodziński |
Journal of Diabetes and its Complications | 2020 |
Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues
M Gliozzi, V Musolino, F Bosco, M Scicchitano, F Scarano, S Nucera, MC Zito, S Ruga, C Carresi, R Macrì, L Guarnieri, J Maiuolo, A Tavernese, AR Coppoletta, C Nicita, R Mollace, E Palma, C Muscoli, C Belzung, V Mollace |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2020 |
Simultaneous Cross-Linking and Cross-Polymerization of Enzyme Responsive Polyethylene Glycol Nanogels in Confined Aqueous Droplets for Reduction of Low-Density Lipoprotein Oxidation
S Basak, HA Khare, M Roursgaard, PJ Kempen, JH Lee, S Bazban-Shotorbani, M Kræmer, S Chernyy, TL Andresen, K Almdal, N Kamaly |
Biomacromolecules | 2020 |
İnsan Serum Paraoksonaz-1 (PON1) Üzerine Zoledronik Asit’in İn Vitro İnhibisyon Etkisi
H SÖYÜT, Y ULUTAŞ, E KÖKSAL |
2020 | |
Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders
Meneses, Silvestre, SL, Macedo |
International journal of molecular sciences | 2019 |
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
C Cervellati, G Valacchi, V Tisato, G Zuliani, J Marsillach |
Minerva medica | 2019 |
Comparative analysis of plasma total antioxidant capacity in patients with hyperglycemia and hyperglycemia plus dyslipidemia
V Vichaibun, K Khananurak, T Sophonnithiprasert |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2019 |
Interaction between MTHFR 677C>T, PON1 192Q>R and PON1 55L>M polymorphisms and its effect on non-recurrent spontaneous abortion in Mexican women
J Blanco-Muñoz, M Lacasaña, R Gamboa, C Huesca-Gómez, JÁ Hernández-Mariano, C Aguilar-Garduño |
Gene | 2019 |
Hepatoprotective immune response during Trichinella spiralis infection in mice
AS FARID, EM FATH, S MIDO, N NONAKA, Y HORII |
Journal of Veterinary Medical Science | 2019 |
Epimedium koreanum Extract and Its Flavonoids Reduced Atherosclerotic Risk via Suppressing Modification of Human HDL
JY Kim, SH Shim |
Nutrients | 2019 |
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery
A Wysocka, M Cybulski, A P.Wysokiński, H Berbeć, J Stążka, T Zapolski |
Journal of Clinical Medicine | 2019 |
Organochlorine and organophosphorous pesticides may induce colorectal cancer; A case-control study
M Abolhassani, G Asadikaram, P Paydar, H Fallah, M Aghaee-Afshar, V Moazed, H Akbari, SD Moghaddam, A Moradi |
Ecotoxicology and Environmental Safety | 2019 |
Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis
HS Nalkiran, SB Sahin, T Ayaz, I Nalkiran, AI Guzel, T Eldes, Y Yildiz |
Biomarkers in Medicine | 2019 |
Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
D Levy, CO Reichert, SP Bydlowski |
Antioxidants | 2019 |
Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
JP Corsetti, CE Sparks, RW James, SJ Bakker, RP Dullaart |
Journal of Clinical Medicine | 2019 |
Lipoproteins in Atherosclerosis Process
V Arnao, A Tuttolomondo, M Daidone, A Pinto |
Current medicinal chemistry | 2019 |
Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity
A Yılmaz, E Dilek |
Protein and peptide letters | 2019 |
Intravenous laser wavelength radiation effect on LCAT, PON1, catalase, and FRAP in diabetic rats
A Amjadi, H Mirmiranpour, SO Sobhani, NM Goudarzi |
Lasers in Medical Science | 2019 |
Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs
C Türkeş |
Protein and peptide letters | 2019 |
Antibiyotik Olarak Kullanılan Sultamisilin, Sefdinir, Vankomisin Hidroklorür ve Kolistin Etken Maddelerinin İnsan Serum Paraoksonaz1 Enzim Aktivitesi Üzerine in vitro Etkilerinin İncelenmesi
E Dilek, MB ÖZÇELİK, S YILDIRIM |
2019 | |
PON1 arylesterase activity, HDL functionality and their correlation in malnourished children
MR Mogarekar, MG Dhabe, MM Palmate |
Journal of Pediatric Endocrinology and Metabolism | 2019 |
Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients
S Iftimie, A Escribano, A Díez-Sans, I Albiciuc, A Hernández-Aguilera, I Fort-Gallifa, AF López-Azcona, J Camps, J Joven, A Castro |
Journal of Investigative Surgery | 2019 |
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL
KH Cho |
2019 | |
Associations between nine candidate genetic polymorphisms with coronary heart disease: A meta-analysis
Q Li, Q Du |
Herz | 2019 |
Anti-inflammatory, anti-oxidant and hepatoprotective effects of lactoferrin in rats
AS Farid, MA Shemy, E Nafie, AM Hegazy, EY Abdelhiee |
Drug and Chemical Toxicology | 2019 |
Aspirinin insan kaynaklı hepatoma hücrelerinde paraoksonaz enzimlerinin protein düzeylerine ve arilesteraz aktivitesine etkisi
E Özgün, GS Özgün |
2019 | |
Bazı antrakinonların insan paraoksonaz 1 (hPON1) üzerine etkilerinin incelenmesi
B GÖKÇE |
2019 | |
In Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor
C Türkeş, Ş Beydemir, Öİ Küfrevioğlu |
ChemistrySelect | 2019 |
Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction
Erdoğan Sökmen, Mustafa Çelik, Serkan Sivri, Kenan Güçlü |
The Journal of Tehran University Heart Center | 2019 |
The effect of coenzyme Q and selenium on kidney in rats with partial unilateral ureteral obstruction
MK Kirdag, D Tuglu, E Yuvanc, U Kisa, M Balci, E Batislam, E Yilmaz |
Türk Üroloji Dergisi/Turkish Journal of Urology | 2019 |
High-Density Lipoproteins
A Haghikia, U Landmesser |
Cardiology Clinics | 2018 |
Functional features of the “finger” domain of the DEG/ENaC channels MEC-4 and UNC-8
C Matthewman, CK Johnson, DM Miller, L Bianchi |
American journal of physiology. Cell physiology | 2018 |
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
A Passaro, GB Vigna, A Romani, JM Sanz, C Cavicchio, G Bonaccorsi, G Valacchi, C Cervellati |
Oxidative medicine and cellular longevity | 2018 |
Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis
G Marek, M Ściskalska, Z Grzebieniak, H Milnerowicz |
International journal of medical sciences | 2018 |
Paraoxonase activity in metabolic syndrome in children and adolescents
Adhe-Rojekar A, Mogarekar MR, Rojekar MV |
Caspian Journal of Internal Medicine | 2018 |
Effect of Atorvastatin on Serum Para-Oxonase-1 and C-Reactive Protein in Wistar Rats
A Marathe, B Ganaraja, KA Shenoy, KA Prabhu, M Nandini |
Indian Journal of Clinical Biochemistry | 2018 |
A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3
Q Zhang, X Xiao, J Zheng, M Li, M Yu, F Ping, T Wang, X Wang |
BioMed Research International | 2018 |
Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders
M Yusuf, M Khan, MA Robaian, RA Khan |
Biological Chemistry | 2018 |
Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity
Y Torres-Ramos, A Montoya-Estrada, B Cisneros, K Tercero-Pérez, G León-Reyes, N Leyva-García, O Hernández-Hernández, JJ Magaña |
The Cerebellum | 2018 |
Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
G León-Reyes, SE y Sosa, R Medina-Navarro, AM Guzmán-Grenfell, AX Medina-Urrutia, S Fuentes-García, GJ Hicks, YD Torres-Ramos |
Lipids in Health and Disease | 2018 |
Alterations in haemolymph proteome of Mytilus galloprovincialis mussel after an induced injury
L Franco-Martínez, S Martínez-Subiela, D Escribano, S Schlosser, K Nöbauer, E Razzazi-Fazeli, D Romero, JJ Cerón, A Tvarijonaviciute |
Fish & Shellfish Immunology | 2018 |
Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
M Idrees, AR Siddiq, M Ajmal, M Akram, RR Khalid, A Hussain, R Qamar, H Bokhari |
Genetics and molecular biology | 2018 |
Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women
KH Park, D Yadav, SJ Kim, JR Kim, KH Cho |
Frontiers in Endocrinology | 2018 |
Ethnic Disparities in Endothelial Function and Its Cardiometabolic Correlates: The Pathobiology of Prediabetes in A Biracial Cohort Study
I Owei, N Umekwe, H Mohamed, S Ebenibo, J Wan, S Dagogo-Jack |
Frontiers in Endocrinology | 2018 |
Terminalia pallida fruit ethanolic extract ameliorates lipids, lipoproteins, lipid metabolism marker enzymes and paraoxonase in isoproterenol-induced myocardial infarcted rats
AH Shaik, NR Shaik, AK Mohammed, SY Omar, A Mohammad, TA Mohaya, LD Kodidhela |
Saudi Journal of Biological Sciences | 2018 |
Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
GA Asare, SE Andam, H Asare-Anane, S Ammanquah, Y Anang-Quartey, DK Afriyie, I Musah |
Prostate International | 2018 |
Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease: A meta-analysis in the Chinese population
Z Deng, H Xiang, W Gao |
Herz | 2018 |
Therapeutic potentials of propolis and pollen on biochemical changes in reproductive function of L-NAME induced hypertensive male rats
MF Gulhan |
Clinical and Experimental Hypertension | 2018 |
Associations of the PON1 rs662 polymorphism with circulating oxidized low-density lipoprotein and lipid levels: a systematic review and meta-analysis
Z Luo, L Pu, I Muhammad, Y Chen, X Sun |
Lipids in Health and Disease | 2018 |
Long-Term Supplementation of Black Elderberries Promotes Hyperlipidemia, but Reduces Liver Inflammation and Improves HDL Function and Atherosclerotic Plaque Stability in Apolipoprotein E-Knockout Mice
CL Millar, GH Norris, C Jiang, J Kry, A Vitols, C Garcia, YK Park, JY Lee, CN Blesso |
Molecular Nutrition & Food Research | 2018 |
Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues
O Rom, N Volkova, H Jeries, C Grajeda-Iglesias, M Aviram |
Lipids | 2018 |
The Role of Acetylcholinesterase, Paraxonase, and Oxidative Stress in Breast Tumors
P Paydar, G Asadikaram, HZ Nejad, V Moazed, B Poursayedi, MH Nematollahi, H Akbari, M Abolhassani, FK Shadmani |
International Journal of Cancer Management | 2018 |
Pulmonary Health and Disorders
M Pokorski |
2018 | |
Pulmonary Health and Disorders
M Pokorski |
2018 | |
Pulmonary Health and Disorders
M Pokorski |
2018 | |
Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines
B Chao, BX Li, X Xiao |
Bioorganic & Medicinal Chemistry Letters | 2017 |
Paraoxonase and atherosclerosis-related cardiovascular diseases
DA Chistiakov, AA Melnichenko, AN Orekhov, YV Bobryshev |
Biochimie | 2017 |
Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology
E Strauss, W Supinski, A Radziemski, G Oszkinis, AL Pawlak, J Gluszek |
International Journal of Cardiology | 2017 |
Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
D Blaha-Nelson, DM Krüger, K Szeler, M Ben-David, SC Kamerlin |
Journal of the American Chemical Society | 2017 |
Could high-density lipoprotein cholesterol predict increased cardiovascular risk?:
TI Chang, E Streja, H Moradi |
Current opinion in endocrinology, diabetes, and obesity | 2017 |
Paraoxonase-1 activity is related to Trichinella spiralis -induced hepatitis in rats
AS Farid, EM Fath, S Mido, N Nonaka, Y Horii |
European Journal of Clinical Investigation | 2017 |
The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein
F Ito, T Ito, C Suzuki, T Yahata, K Ikeda, K Hamaoka |
International journal of molecular sciences | 2017 |
The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases
J Lou-Bonafonte, C Gabás-Rivera, M Navarro, J Osada |
International journal of molecular sciences | 2017 |
Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk—an exploratory study
K Declerck, S Remy, C Wohlfahrt-Veje, KM Main, GV Camp, G Schoeters, WV Berghe, HR Andersen |
Clinical Epigenetics | 2017 |
Oxidative profiles of LDL and HDL isolated from women with preeclampsia
G León-Reyes, RF Maida-Claros, AX Urrutia-Medina, E Jorge-Galarza, AM Guzmán-Grenfell, S Fuentes-García, R Medina-Navarro, MA Moreno-Eutimio, JL Muñoz-Sánchez, JJ Hicks, YD Torres-Ramos |
Lipids in Health and Disease | 2017 |
Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome
K Osei, T Gaillard |
Frontiers in Endocrinology | 2017 |
Phytochemical Constituents, Health Benefits, and Industrial Applications of Grape Seeds: A Mini-Review
Z Ma, H Zhang |
Antioxidants | 2017 |
High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?: Editorial comment
O Rom, M Aviram |
European Journal of Heart Failure | 2017 |
Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: A key role for triglyceride metabolism
O Rom, C Grajeda-Iglesias, M Najjar, N Abu-Saleh, N Volkova, DE Dar, T Hayek, M Aviram |
The Journal of Nutritional Biochemistry | 2017 |
Paraoxonases and infectious diseases
J Camps, S Iftimie, A García-Heredia, A Castro, J Joven |
Clinical Biochemistry | 2017 |
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL 2 and HDL 3
K Griffiths, A Pazderska, M Ahmed, A McGowan, AP Maxwell, J McEneny, J Gibney, GJ McKay |
Journal of Diabetes Research | 2017 |
Correlation of PON1 polymorphisms with ankylosing spondylitis susceptibility: A case–control study in Chinese Han population
H Xu, Y Qu |
Medicine | 2017 |
The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients
SH Liu, CY Chen, YJ Li, HH Wu, CY Lin, YC Chen, MY Chang, HH Hsu, CL Ku, YC Tian |
Therapeutics and Clinical Risk Management | 2017 |
Paraoxonase and arylesterase activity in bladder cancer
MM Utangac, E Yeni, M Savas, A Altunkol, H Ciftci, K Gumus, M Demir |
Türk Üroloji Dergisi/Turkish Journal of Urology | 2017 |
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL 2 and HDL 3
K Griffiths, A Pazderska, M Ahmed, A McGowan, AP Maxwell, J McEneny, J Gibney, GJ McKay |
Journal of Diabetes Research | 2017 |
Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering
M Purg, M Elias, SC Kamerlin |
Journal of the American Chemical Society | 2017 |
Low-dose grape pomace and omija fruit extract is more effective than high-dose in lowering oxidative stress and fat-pad mass in db/db mice
SJ Cho, HJ Kim, JY Choi, EY Kwon, YJ Kim, R Ryu, MS Choi, YB Park |
Food Science and Biotechnology | 2017 |
Alteration of paraoxonase, arylesterase and lactonase activities in people around fluoride endemic area of Tamil Nadu, India
M Arulkumar, R Vijayan, S Penislusshiyan, P Sathishkumar, J Angayarkanni, T Palvannan |
Clinica Chimica Acta | 2017 |
ATHEROTHROMBOSIS AND OXIDATIVE STRESS: MECHANISMS AND MANAGEMENT IN ELDERLY
F Violi, L Loffredo, R Carnevale, P Pignatelli, D Pastori |
Antioxidants & Redox Signaling | 2017 |
Serum paraoxonase activity in patients with ischaemic and nonischaemic dilated cardiomyopathy
F Gungoren, T Senturk, A Ozturk, K Koz, E Sarandol, D Yesilbursa, S Gullulu, G Ozkaya, A Aydinlar |
Acta Cardiologica | 2017 |
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation
A Tajbakhsh, M Rezaee, M Rivandi, F Forouzanfar, F Afzaljavan, A Pasdar |
Clinical Biochemistry | 2017 |
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
C Cervellati, G Bonaccorsi, A Trentini, G Valacchi, JM Sanz, M Squerzanti, M Spagnolo, L Massari, I Crivellari, P Greco, R Parladori, A Passaro, G Ricci |
Scandinavian Journal of Clinical & Laboratory Investigation | 2017 |
The role of paraoxonase in cancer
T Bacchetti, G Ferretti, A Sahebkar |
Seminars in Cancer Biology | 2017 |
A case-control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus
JA Crow, EC Meek, RW Wills, JE Chambers |
Diabetes/Metabolism Research and Reviews | 2017 |
SERUM PARAOXONASE ACTIVITY IN RENAL TRANSPLANT RECIPIENTS
S Gadicherla, S M.N, P Doddamani |
2017 | |
Combined Effects of Curcumin and Lycopene or Bixin in Yoghurt on Inhibition of LDL Oxidation and Increases in HDL and Paraoxonase Levels in Streptozotocin-Diabetic Rats.
Assis RP, Arcaro CA, Gutierres VO, Oliveira JO, Costa PI, Baviera AM, Brunetti IL |
International journal of molecular sciences | 2017 |
Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA
S Jayaraman, C Haupt, O Gursky |
Journal of lipid research | 2016 |
Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ-LXRα-ABCA1 pathway
S Ikhlef, H Berrougui, OK Simo, A Khalil |
FEBS Letters | 2016 |
HDL—A molecule with a multi-faceted role in coronary artery disease
S Arora, SK Patra, R Saini |
Clinica Chimica Acta | 2016 |
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study
E Dounousi, I Bouba, B Spoto, K Pappas, G Tripepi, I Georgiou, A Tselepis, M Elisaf, D Tsakiris, C Zoccali, K Siamopoulos |
Oxidative medicine and cellular longevity | 2016 |
Concentration of Smaller High‐Density Lipoprotein Particle (HDL‐P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)
DS Kim, YK Li, GA Bell, AA Burt, T Vaisar, PM Hutchins, CE Furlong, JD Otvos, JF Polak, MK Arnan, JD Kaufman, RL McClelland, WT Longstreth, GP Jarvik |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2016 |
iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis
M Luczak, D Formanowicz, Ł Marczak, J Suszyńska-Zajczyk, E Pawliczak, M Wanic-Kossowska, M Stobiecki |
Scientific Reports | 2016 |
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
M Castellazzi, A Trentini, A Romani, G Valacchi, T Bellini, G Bonaccorsi, E Fainardi, C Cavicchio, A Passaro, G Zuliani, C Cervellati |
The International Journal of Biochemistry & Cell Biology | 2016 |
Caenorhabditis elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins
Y Chen, S Bharill, Z Altun, R OHagan, B Coblitz, EY Isacoff, M Chalfie |
Molecular biology of the cell | 2016 |
Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients
I Potočnjak, V Degoricija, M Trbušić, SD Terešak, B Radulović, G Pregartner, A Berghold, B Tiran, G Marsche, S Frank, L Calabresi |
PloS one | 2016 |
A review of paraoxonase 1 properties and diagnostic applications
M Kulka |
Polish Journal of Veterinary Sciences | 2016 |
Increased presence of oxidized low‐density lipoprotein in the left ventricular blood of subjects with cardiovascular disease
CA Narasimhulu, D Litvinov, B Sengupta, D Jones, C SaiSudhakar, M Firstenberg, B Sun, S Parthasarathy |
Physiological Reports | 2016 |
Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers
R Varatharajalu, M Garige, LC Leckey, K Reyes-Gordillo, R Shah, MR Lakshman |
Oxidative medicine and cellular longevity | 2016 |
Meta-markers for the differential diagnosis of lung cancer and lung disease
YI Kim, JM Ahn, HJ Sung, SS Na, J Hwang, Y Kim, JY Cho |
Journal of Proteomics | 2016 |
A study of paraoxonase1 (PON1) activities, HDL cholesterol and its association with vascular complication in type 2 diabetes mellitus
MR Mogarekar, MG Dhabe, CC Gujrathi |
International Journal of Diabetes in Developing Countries | 2016 |
The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality
M Malara, A Kęska, G Lutosławska |
Biomedical Human Kinetics | 2016 |
Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis
CA Narasimhulu, K Selvarajan, KY Burge, D Litvinov, B Sengupta, S Parthasarathy |
Journal of Medicinal Food | 2016 |
Paraoxonase 1 (PON1) and pomegranate influence circadian gene expression and period length
U Loizides-Mangold, M Koren-Gluzer, S Skarupelova, AM Makhlouf, T Hayek, M Aviram, C Dibner |
Chronobiology International | 2016 |
Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients
J Ivanišević, J Kotur-Stevuljević, A Stefanović, S Spasić, VV Mihailović, JV Ivanov, Z Jelić-Ivanović |
European Journal of Clinical Investigation | 2016 |
Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk
P Celada, FJ Sánchez-Muniz, G Delgado-Pando, S Bastida, ME Rodilla, F Jiménez-Colmenero, B Olmedilla-Alonso |
Journal of Physiology and Biochemistry | 2016 |
Atherosclerosis — do we know enough already to prevent it?
CA Narasimhulu, I Fernandez-Ruiz, K Selvarajan, X Jiang, B Sengupta, A Riad, S Parthasarathy |
Current Opinion in Pharmacology | 2016 |
Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease
A Zinellu, AG Fois, S Sotgia, E Zinellu, F Bifulco, G Pintus, AA Mangoni, C Carru, P Pirina |
European Journal of Clinical Investigation | 2016 |
Antioxidative Activity after Rosuvastatin Treatment in Patients with Stable Ischemic Heart Disease and Decreased High Density Lipoprotein Cholesterol
DS Park, KH Yun, HY Park, SJ Rhee, NH Kim, SK Oh, JW Jeong |
Korean Circulation Journal | 2016 |
Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents
DG Mata, P Sabnekar, CA Watson, PE Rezk, N Chilukuri |
Chemico-Biological Interactions | 2016 |
Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes
T Gaillard, K Osei |
BMJ Open Diabetes Research & Care | 2016 |
Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients
K AnandBabu, SR Bharathidevi, S Sripriya, P Sen, VJ Prakash, A Bindu, N Viswanathan, N Angayarkanni |
Experimental Eye Research | 2016 |
The Early Effect of Carotid Artery Stenting on Antioxidant Capacity and Oxidative Stress in Patients with Carotid Artery Stenosis
S Michalak, W Ambrosius, E Wysocka, M Dziarmaga, R Juszkat, A Wykretowicz, W Kozubski |
Oxidative medicine and cellular longevity | 2016 |
High morning blood pressure surge is associated with oxidative stress and paraoxonase 1 activity in newly diagnosed hypertensive patients
O Kaypaklı, M Gür, H Harbalıoğlu, T Şeker, Ş Selek |
Clinical and Experimental Hypertension | 2016 |
In vitro effects of exogenous carbon monoxide on oxidative stress and lipid metabolism in macrophages
L Petrick, M Rosenblat, M Aviram |
Toxicology and industrial health | 2016 |
Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score
A Souza-Nogueira, AE Camargo, FA Remondi, MM Paoliello, RJ Richter, CE Furlong, DS Barbosa, M Maes, EG Moreira |
Archives of Endocrinology and Metabolism | 2016 |
Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot
S MUHTAROĞLU, DB KETİ, K ÜNLÜHİZARCI |
TURK J MED SCI | 2016 |
Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women
GR Nalcakan, SR Varol, F Turgay, M Nalcakan, MZ Ozkol, SO Karamizrak |
Journal of Sport and Health Science | 2016 |
ASSESSMENT OF PARAOXONASE-1 ACTIVITY IN DIABETES MELLITUS
R Mathivanan, S Natarajan, S Subramaniyam |
2016 | |
Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
Souza-Nogueira A, Camargo AE, Remondi FA, Paoliello MM, Richter RJ, Furlong CE, Barbosa DS, Maes M, Moreira EG |
Archives of Endocrinology and Metabolism | 2016 |
Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice
N Farrell, G Norris, SG Lee, OK Chun, CN Blesso |
Food & Function | 2015 |
Oxidative stress in chronic vascular disease: From prediction to prevention
F Santilli, D D'Ardes, G Davì |
Vascular Pharmacology | 2015 |
The chemistry and pharmacology of privileged pyrroloquinazolines
B Chao, BX Li, X Xiao |
MedChemComm | 2015 |
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
J Salazar, LC Olivar, E Ramos, M Chávez-Castillo, J Rojas, V Bermúdez |
Cholesterol | 2015 |
Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction
X Gu, Y Huang, BS Levison, G Gerstenecker, AJ DiDonato, LB Hazen, J Lee, V Gogonea, JA DiDonato, SL Hazen |
The Journal of biological chemistry | 2015 |
PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity
DS Kim, AA Burt, JE Ranchalis, S Vuletic, T Vaisar, WF Li, EA Rosenthal, W Dong, JF Eintracht, AG Motulsky, JD Brunzell, JJ Albers, CE Furlong, GP Jarvik |
Journal of lipid research | 2015 |
Cholesterol Metabolism in CKD
AB Reiss, I Voloshyna, JD Leon, N Miyawaki, J Mattana |
American Journal of Kidney Diseases | 2015 |
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
M Mackness, B Mackness |
Gene | 2015 |
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
N Apostolova, VM Victor |
Antioxidants & Redox Signaling | 2015 |
Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: A marker of atherosclerosis in patients with normal cholesterol levels
F Wang, Y Liu, Y Cong, P Li, Y Li, Z Yan, Y Tang, Y Cheng, Y Zheng |
Clinica Chimica Acta | 2015 |
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study
C Cervellati, A Trentini, A Romani, T Bellini, C Bosi, B Ortolani, A Zurlo, A Passaro, D Seripa, G Zuliani |
Journal of Neurochemistry | 2015 |
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
G Ferretti, T Bacchetti, A Sahebkar |
Progress in Lipid Research | 2015 |
Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis
M Krüger, AM Pabst, B Al-Nawas, S Horke, M Moergel |
Journal of Cancer Research and Clinical Oncology | 2015 |
Therapeutic Potential of Ocimum tenuiflorum as MPO Inhibitor with Implications for Atherosclerosis Prevention
CA Narasimhulu, S Vardhan |
Journal of Medicinal Food | 2015 |
Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies
A Younis |
Medical science monitor : international medical journal of experimental and clinical research | 2015 |
Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects:
M Yuksel, A Yildiz, E Tekbas, E Gunduz, A Ekinci, MZ Bilik, N Ozaydogdu, Z Atilgan |
Medicine | 2015 |
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
M Vaváková, Z Ďuračková, J Trebatická |
Oxidative medicine and cellular longevity | 2015 |
Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model
MJ Kim, M Park, DW Kim, MJ Shin, O Son, HS Jo, HJ Yeo, SB Cho, JH Park, CH Lee, DS Kim, OS Kwon, J Kim, KH Han, J Park, WS Eum, SY Choi |
Biomaterials | 2015 |
PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients
JA de Souza, A Menin, LO Lima, L Smiderle, MH Hutz, CR van der Sand, LC van der Sand, ME Ferreira, RC Pires, S Almeida, M Fiegenbaum |
Clinical Biochemistry | 2015 |
Association Between Paraoxonase Gene Polymorphisms and Intracerebral Hemorrhage in a Korean Population
HJ Park, SK Kim, HK Park, JH Chung |
Journal of Molecular Neuroscience | 2015 |
Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction
MF Rahman, IM Hashad, K Abou-Aisha, SM Abdel-Maksoud, MZ Gad |
Archives of Medical Science : AMS | 2015 |
Atherosclerosis: Risks, Mechanisms, and Therapies
HJ Pownall, C Rosales, BK Gillard, AM Gotto |
Atherosclerosis: Risks, Mechanisms, and Therapies | 2015 |
Glucomannan and glucomannan plus spirulina added to pork significantly block dietary cholesterol effects on lipoproteinemia, arylesterase activity, and CYP7A1 expression in Zucker fa/fa rats
L González-Torres, M Vázquez-Velasco, R Olivero-David, S Bastida, J Benedí, RR González, MJ González-Muñoz, FJ Sánchez-Muniz |
Journal of Physiology and Biochemistry | 2015 |
Cardiovascular protective effect of glabridin: Implications in LDL oxidation and inflammation
MR Kang, KH Park, SJ Oh, J Yun, CW Lee, MY Lee, SB Han, JS Kang |
International Immunopharmacology | 2015 |
Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders
P Factor-Livak |
Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders | 2015 |
Effects of Anaerobic Training on Paraoxonase-1 Enzyme (PON1) Activities of High Density Lipoprotein Subgroups and Its Relationship with PON1-Q192R Phenotype
F Turgay, AR Şişman, AÇ Aksu |
Journal of Atherosclerosis and Thrombosis | 2015 |
Serum paraoxonase and arylesterase activities in patients with chronic otitis media
M Turan, R Ucler, M Aslan, F Kalkan, A Taskın, MF Garca, H Cankaya |
Redox Report | 2015 |
Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells
N Ponce-Ruiz, AE Rojas-García, BS Barrón-Vivanco, G Elizondo, YY Bernal-Hernández, A Mejía-García, IM Medina-Díaz |
Toxicology in Vitro | 2015 |
Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients
SS Chawhan |
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2015 |
Oxidative Stress and Paraoxonase 1 Activity Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
A Börekçi, M Gür, C Türkoğlu, M Çaylı, Ş Selek, O Kaypaklı, H Uçar, M Coşkun, T Şeker, M Koç, T Gökdeniz, MY Gözükara |
Angiology | 2015 |
Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy
O Hussein, L Izikson, Y Bathish, E Dabur, A Hanna, J Zidan |
Journal of Psychopharmacology (Oxford, England) | 2015 |
Silicon-Enriched Restructured Pork Affects the Lipoprotein Profile, VLDL Oxidation, and LDL Receptor Gene Expression in Aged Rats Fed an Atherogenic Diet
A Garcimartín, JA Santos-López, S Bastida, J Benedí, FJ Sánchez-Muniz |
The Journal of nutrition | 2015 |
SERUM PARAOXONASE ACTIVITY AND ITS RELATION TO SERUM LIPIDS IN CORONARY ARTERY DISEASE
RS Nair, SS Nair, SB M |
2015 | |
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils
OF Sharifov, X Xu, A Gaggar, EM Tabengwa, CR White, MN Palgunachari, GM Anantharamaiah, H Gupta |
Inflammation | 2014 |
Regulation of Endothelial Nitric Oxide Synthase and High-Density Lipoprotein Quality by Estradiol in Cardiovascular Pathology
KE Kypreos, S Zafirovic, PI Petropoulou, P Bjelogrlic, I Resanovic, A Traish, ER Isenovic |
Journal of cardiovascular pharmacology and therapeutics | 2014 |
Impairment of High-Density Lipoprotein Resistance to Lipid Peroxidation and Adipose Tissue Inflammation in Obesity Complicated by Obstructive Sleep Apnea
R Yadav, M France, R Aghamohammadzadeh, Y Liu, S Hama, S Kwok, J Schofield, P Turkington, AA Syed, R Malik, P Pemberton, A Greenstein, P Durrington, B Ammori, M Gibson, M Jeziorska, H Soran |
The Journal of clinical endocrinology and metabolism | 2014 |
HDL-3 is a Superior Predictor of Carotid Artery Disease in a Case-Control Cohort of 1725 Participants
DS Kim, AA Burt, EA Rosenthal, JE Ranchalis, JF Eintracht, TS Hatsukami, CE Furlong, S Marcovina, JJ Albers, GP Jarvik |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Anthocyanin Supplementation Improves HDL-Associated Paraoxonase 1 Activity and Enhances Cholesterol Efflux Capacity in Subjects With Hypercholesterolemia
Y Zhu, X Huang, Y Zhang, Y Wang, Y Liu, R Sun, M Xia |
The Journal of clinical endocrinology and metabolism | 2014 |
The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats
RS Strakovsky, X Zhang, D Zhou, YX Pan |
The Journal of Nutritional Biochemistry | 2014 |
Advances in Experimental Medicine and Biology
A Devarajan, D Shih, ST Reddy |
Advances in experimental medicine and biology | 2014 |
Role of Oxidative Stress in Chronic Diseases
M Ghashghaeinia, T Wieder, M Duszenko |
Role of Oxidative Stress in Chronic Diseases | 2014 |
Protective Effects of Sea Spaghetti-Enriched Restructured Pork Against Dietary Cholesterol: Effects on Arylesterase and Lipoprotein Profile and Composition of Growing Rats
AR Moreira, R Olivero-David, M Vázquez-Velasco, L González-Torres, J Benedí, S Bastida, FJ Sánchez-Muniz |
Journal of Medicinal Food | 2014 |
Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh |
Journal of Cellular and Molecular Medicine | 2014 |
Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis
M Gür, M Çaylı, H Uçar, Z Elbasan, DY Şahin, MY Gözükara, Ş Selek, NY Koyunsever, T Şeker, C Türkoğlu, O Kaypaklı, N Aksoy |
The International Journal of Cardiovascular Imaging | 2014 |
Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?
L Shema-Didi, B Kristal, S Sela, R Geron, L Ore |
Nutrition Journal | 2014 |
Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus
AJ Rani, SV Mythili |
Journal of Clinical and Diagnostic Research : JCDR | 2014 |
Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease
MH Hampe, MR Mogarekar |
Indian journal of human genetics | 2014 |
Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan
D Kumar, SI Rizvi |
The Scientific World JOURNAL | 2014 |
Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina
S Siewert, II Gonzalez, RO Lucero, MS Ojeda |
Journal of Diabetes Investigation | 2014 |
HDL-cholesterol in coronary artery disease risk: Function or structure?
Ó Pérez-Méndez, HG Pacheco, C Martínez-Sánchez, M Franco |
Clinica Chimica Acta | 2014 |
Novel Study on N-Nitrosamines as Risk Factors of Cardiovascular Diseases
SA Sheweita, HA El-Bendery, MH Mostafa |
BioMed Research International | 2014 |
An assessment of antioxidant status in patients with carbon monoxide poisoning
S Zengin, B A, S Karta, B Can, M Orkmez, A Taskin, U Lok, B Gulen, C Yildirim, S Taysi |
World Journal of Emergency Medicine | 2014 |
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
Y Haraguchi, R Toh, M Hasokawa, H Nakajima, T Honjo, K Otsui, K Mori, M Miyamoto-Sasaki, M Shinohara, K Nishimura, T Ishida, K Hirata |
Atherosclerosis | 2014 |
HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: In vivo and in vitro studies: HDL3 Stimulates PON1 Antiatherogenic Properties
M Rosenblat, N Volkova, M Aviram |
BioFactors | 2014 |
Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress
C Türkeş, H Söyüt, Ş Beydemir |
Pharmacological Reports | 2014 |
Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium
C Türkeş, H Söyüt, Ş Beydemir |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2014 |
Paraoxonase1 Genetic Polymorphisms in a Mixed Ancestry African Population
M Macharia, AP Kengne, DM Blackhurst, RT Erasmus, TE Matsha |
Mediators of Inflammation | 2014 |
PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans
MP Kasprzak, M Iskra, W Majewski, M Budzyń-Napierała, B Gryszczyńska, K Strzyżewski, J Kasprzak |
Archives of Medical Science : AMS | 2014 |
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
H El-Banna, A Jiman-Fatani |
BMC musculoskeletal disorders | 2014 |
Adherence to Mediterranean diet during pregnancy and serum lipid, lipoprotein and homocysteine concentrations at birth
E Gesteiro, S Bastida, BR Bernal, FJ Sánchez-Muniz |
European Journal of Nutrition | 2014 |
Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes
SJ Healy, K Osei, T Gaillard |
Diabetes care | 2014 |
Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants
D Kim, AA Burt, JE Ranchalis, LE Jarvik, JF Eintracht, CE Furlong, GP Jarvik |
Nutrition & Metabolism | 2014 |
Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats
S Taş, E Sarandöl, M Dirican |
The Scientific World JOURNAL | 2014 |
Affective and inflammatory responses among orchestra musicians in performance situation
A Pilger, H Haslacher, E Ponocny-Seliger, T Perkmann, K Böhm, A Budinsky, A Girard, K Klien, G Jordakieva, L Pezawas, O Wagner, J Godnic-Cvar, R Winker |
Brain, Behavior, and Immunity | 2014 |
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: The role of activity-determined PON1 192Q/R phenotypes
A Mahrooz, A Alizadeh, G Gohari |
Journal of the Neurological Sciences | 2014 |
Plasma paraoxonase and arylesterase activities in smokers and smokeless tobacco users as Maraş powder
N Kurtul, S Söylemez, M Çelik |
Inhalation Toxicology | 2014 |
Identification by a proteomic approach of a plasma protein as a possible biomarker of illicit dexamethasone treatment in veal calves
C Guglielmetti, M Mazza, M Pagano, S Carrella, S Sciuto, S Nodari, M Pezzolato, GB Richelmi, E Baioni, M Caramelli, PL Acutis, E Bozzetta |
Food Additives & Contaminants: Part A | 2014 |
Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow
M Gür, C Türkoğlu, A Taşkın, H Uçar, A Börekçi, T Şeker, MY Gözükara, O Kaypaklı, S Akyol, Ş Selek, DY Şahin, Z Elbasan, M Çaylı |
Atherosclerosis | 2014 |
Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma
UU Malik, IA Siddiqui, Z Hashim, S Zarina |
Clinica Chimica Acta | 2014 |
Onion extract ( Allium cepa L.), quercetin and catechin up-regulate paraoxonase 1 activity with concomitant protection against low-density lipoprotein oxidation in male Wistar rats subjected to oxidative stress: Up-regulation of PON1 activity and protection of LDL oxidation by onion extract and flavonoids
N Jaiswal, SI Rizvi |
Journal of the Science of Food and Agriculture | 2014 |
Activation of paraoxonase 1 is associated with HDL remodeling ex vivo
A Gugliucci |
Clinica Chimica Acta | 2014 |
The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome
D Kocer, F Bayram, H Diri |
Gynecological Endocrinology | 2014 |
Decreased serum paraoxonase and arylesterase activities in patients with rosacea
Z Takci, SG Bilgili, AS Karadag, ME Kucukoglu, S Selek, M Aslan |
Journal of the European Academy of Dermatology and Venereology | 2014 |
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major depression and bipolar disorder
CC Bortolasci, HO Vargas, A Souza-Nogueira, DS Barbosa, EG Moreira, SO Nunes, M Berk, S Dodd, M Maes |
Journal of Affective Disorders | 2014 |
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease
A Kratzer, H Giral, U Landmesser |
Cardiovascular Research | 2014 |
Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report
S Shahmohamdnejad, A Vaisi-Raygani, Y Shakiba, A Kiani, Z Rahimi, T Pourmotabbed |
Clinical Biochemistry | 2014 |
Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs
G Rossi, J Kuleš, RB Rafaj, V Mrljak, S Lauzi, A Giordano, S Paltrinieri |
Research in Veterinary Science | 2014 |
Associations of High Density Lipoprotein Cholesterol and Framingham Cardiovascular Risk with Diabetic Retinopathy in African Type 2 Diabetics
B Longo-Mbenza, MM Muaka, T Gombet, IL Phemba, S Cook, EM Mengome |
World Journal of Cardiovascular Diseases | 2014 |
Decreased HDL-Dependent Paraoxonase and Arylesterase Enzyme Activity May Indicate a Worse Prognosis in Multiple Myeloma
HY Ellidag, O Aydin, E Eren, N Yilmaz, M Ergin |
Asian Pacific Journal of Cancer Prevention | 2014 |
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
JK Taylor, EP Plaisance, AJ Mahurin, ML Mestek, J Moncada-Jimenez, PW Grandjean |
Redox Report | 2014 |
Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity
CC Bortolasci, HO Vargas, A Souza-Nogueira, EG Moreira, SO Nunes, M Berk, S Dodd, DS Barbosa, M Maes |
Redox Report | 2014 |
Using oxidant and antioxidant levels to predict the duration of both acute peripheral and mesenteric ischemia
S Yazici, S Demirtas, O Guclu, O Karahan, C Yavuz, A Caliskan, B Mavitas |
Perfusion | 2014 |
Multiple Myeloma: Relationship to Antioxidant Esterases
HY Ellidag, E Eren, O Aydin, M Yildirim, C Sezer, N Yilmaz |
Medical Principles and Practice | 2014 |
Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane
H Hagmann, A Kuczkowski, M Ruehl, T Lamkemeyer, S Brodesser, S Horke, S Dryer, B Schermer, T Benzing, PT Brinkkoetter |
The FASEB Journal | 2014 |
Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients: GGT and Hypertension
MY Gözükara, A Börekçi, M Gür, N Aksoy, T Şeker, O Kaypaklı, H Uçar, C Türkoğlu, M Koç, İ Makca, S Akyol, Ş Selek, M Çaylı |
Journal of Clinical Laboratory Analysis | 2014 |
Free Radicals in Human Health and Disease
V Rani, UC Yadav |
2014 | |
An assessment of antioxidant status in patients with carbon monoxide poisoning
S Zengin, B A, S Karta, B Can, M Orkmez, A Taskın, U Lok, B Gulen, C Yildirim, S Taysi |
World Journal of Emergency Medicine | 2014 |
Myeloperoxidase, paraoxonase-1 and HDL form a functional ternary complex
Ying Huang, Zhiping Wu, Meliana Riwanto, Shengqiang Gao, Bruce Levison, Xiaodong Gu, Xiaoming Fu, Matthew Wagner, Christian Besler, Gary Gerstenecker, Renliang Zhang, Xin-Min Li, Anthony DiDonato, Valentin Gogonea, W.H. Wilson Tang, Jonathan D. Smith, Edward F. Plow, Paul L. Fox, Diana Shih, Aldons Lusis, Edward A Fisher, Joseph DiDonato, Ulf Landmesser, Stanley L. Hazen |
Journal of Clinical Investigation | 2013 |
Anti-inflammatory mechanisms of apolipoprotein a-I mimetic Peptide in acute respiratory distress syndrome secondary to sepsis
OF Sharifov, X Xu, A Gaggar, WE Grizzle, VK Mishra, J Honavar, SH Litovsky, MN Palgunachari, CR White, GM Anantharamaiah, H Gupta |
PloS one | 2013 |
Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism
A Dey |
2013 | |
Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism
A Dey |
2013 | |
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease
M Riwanto, U Landmesser |
2013 | |
Redox signaling in cardiovascular health and disease
NR Madamanchi, MS Runge |
Free radical biology & medicine | 2013 |
HDL and cholesterol: life after the divorce?
KC Vickers, AT Remaley |
Journal of lipid research | 2013 |
Aging affects high-density lipoprotein composition and function
M Holzer, M Trieb, V Konya, C Wadsack, A Heinemann, G Marsche |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2013 |
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
AS Shah, L Tan, JL Long, WS Davidson |
Journal of lipid research | 2013 |
Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats
A El-Sisi, S Hegazy, E El-Khateeb |
PPAR Research | 2013 |
Abundance of Plasma Antioxidant Proteins Confers Tolerance to Acute Hypobaric Hypoxia Exposure
G Padhy, NK Sethy, L Ganju, K Bhargava |
High Altitude Medicine & Biology | 2013 |
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease
DS Kim, J Marsillach, CE Furlong, GP Jarvik |
Pharmacogenomics | 2013 |
High-density lipoprotein impedes glycation of low-density lipoprotein
NN Younis, H Soran, V Charlton-Menys, R Sharma, S Hama, P Pemberton, MM Elseweidy, PN Durrington |
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease | 2013 |
Effects on transcriptional regulation and lipid droplet characteristics in the liver of female juvenile pigs after early postnatal feed restriction and refeeding are dependent on birth weight
C Nebendahl, R Krüger, S Görs, E Albrecht, K Martens, S Hennig, N Storm, W Höppner, R Pfuhl, BU Metzler-Zebeli, HM Hammon, CC Metges |
PloS one | 2013 |
Paraoxonase 1 in neurological disorders
T Menini, A Gugliucci |
Redox Report | 2013 |
Cord-blood lipoproteins, homocysteine, insulin sensitivity/resistance marker profile, and concurrence of dysglycaemia and dyslipaemia in full-term neonates of the Mérida Study
E Gesteiro, S Bastida, FJ Sánchez-Muniz |
European Journal of Pediatrics | 2013 |
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure
PC Lee, SL Rhodes, JS Sinsheimer, J Bronstein, B Ritz |
Environment International | 2013 |
The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects
MA Hassan, OS Al-Attas, T Hussain, NM Al-Daghri, MS Alokail, AK Mohammed, B Vinodson |
Molecular and Cellular Biochemistry | 2013 |
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
MR Mogarekar, SJ Talekar |
Indian Journal of Gastroenterology | 2013 |
Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats
OF Sharifov, G Nayyar, VV Ternovoy, VK Mishra, SH Litovsky, MN Palgunachari, DW Garber, GM Anantharamaiah, H Gupta |
Biochemical and Biophysical Research Communications | 2013 |
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
E D’Amico, P Factor-Litvak, RM Santella, H Mitsumoto |
Free radical biology & medicine | 2013 |
Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: A practical zymogram method to assess HDL function
A Gugliucci, R Caccavello, K Kotani, N Sakane, S Kimura |
Clinica Chimica Acta | 2013 |
Distinct composition of human fetal HDL attenuates its anti-oxidative capacity
I Sreckovic, R Birner-Gruenberger, B Obrist, T Stojakovic, H Scharnagl, M Holzer, M Scholler, S Philipose, G Marsche, U Lang, G Desoye, C Wadsack |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2013 |
Association between PON1 genetic polymorphisms and miscarriage in Mexican women exposed to pesticides
J Blanco-Muñoz, C Aguilar-Garduño, R Gamboa-Avila, M Rodríguez-Barranco, O Pérez-Méndez, C Huesca-Gómez, B González-Alzaga, M Lacasaña |
Science of The Total Environment | 2013 |
Niacin Administration Significantly Reduces Oxidative Stress in Patients With Hypercholesterolemia and Low Levels of High-Density Lipoprotein Cholesterol:
S Hamoud, M Kaplan, E Meilin, A Hassan, R Torgovicky, R Cohen, T Hayek |
The American Journal of the Medical Sciences | 2013 |
Soy Protein, Genistein, and Daidzein Improve Serum Paraoxonase Activity and Lipid Profiles in Rheumatoid Arthritis in Rats
M Mohammadshahi, F Haidari, AA Saei, B Rashidi, S Mahboob, MR Rashidi |
Journal of Medicinal Food | 2013 |
Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients
M Eroglu, N Yilmaz, S Yalcinkaya, N Ay, O Aydin, C Sezer |
The Kaohsiung Journal of Medical Sciences | 2013 |
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities
S Shenhar-Tsarfaty, N Waiskopf, K Ofek, L Shopin, S Usher, S Berliner, I Shapira, NM Bornstein, Y Ritov, H Soreq, EB Assayag |
European Journal of Neurology | 2013 |
Oxidant/Antioxidant Status in Cases of Snake Bite
S Zengin, B Al, P Yarbil, S Taysi, H Bilinc, C Yildirim, N Aksoy |
The Journal of Emergency Medicine | 2013 |
Targeting paraoxonase-1 in atherosclerosis
M Mackness, B Mackness |
Expert Opinion on Therapeutic Targets | 2013 |
PON1 gene polymorphisms and plasma PON1 activities in Takayasu's arteritis disease
C Huesca-Gómez, ME Soto, V Castrejón-Téllez, O Pérez-Méndez, R Gamboa |
Immunology Letters | 2013 |
Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
S Aharoni, M Aviram, B Fuhrman |
Atherosclerosis | 2013 |
Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes
AF Hernández, F Gil, M Lacasaña, M Rodríguez-Barranco, A Gómez, D Lozano, A Pla |
Food and Chemical Toxicology | 2013 |
Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway
M Koren-Gluzer, M Aviram, T Hayek |
Atherosclerosis | 2013 |
Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway
CC Cheng, CM Hsueh, CY Chen, TH Chen, SL Hsu |
Biochemical and Biophysical Research Communications | 2013 |
Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion:
M Aviram, J Vaya |
Current Opinion in Lipidology | 2013 |
Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin
G Rossi, A Giordano, F Pezzia, M Kjelgaard-Hansen, S Paltrinieri |
Veterinary Clinical Pathology | 2013 |
Endothelial dysfunction – a major mediator of diabetic vascular disease
CM Sena, AM Pereira, R Seiça |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2013 |
Oxidative stress, hematological and biochemical alterations in farmers exposed to pesticides
T Wafa, K Nadia, N Amel, C Ikbal, T Insaf, K Asma, MA Hedi, H Mohamed |
Journal of Environmental Science and Health, Part B | 2013 |
Effect of vitamins, probiotics and protein level on semen traits and seminal plasma biochemical parameters of post-moult male broiler breeders
RU Khan, ZU Rahman, I Javed, F Muhammad |
British Poultry Science | 2013 |
Biological markers of oxidative stress: Applications to cardiovascular research and practice
E Ho, KK Galougahi, CC Liu, R Bhindi, GA Figtree |
Redox Biology | 2013 |
Molecular dynamics simulation of human serum paraoxonase 1 in DPPC bilayer reveals a critical role of transmembrane helix H1 for HDL association
MC Patra, SN Rath, SK Pradhan, J Maharana, S De |
European Biophysics Journal | 2013 |
Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer
JM Ahn, HJ Sung, YH Yoon, BG Kim, WS Yang, C Lee, HM Park, BJ Kim, BG Kim, SY Lee, HJ An, JY Cho |
Molecular & cellular proteomics : MCP | 2013 |
Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi)
Z Iqbal, ZU Rahman, F Muhammad, T Khaliq, H Anwar, MM Awais, S Sadaf |
BMC veterinary research | 2013 |
Pomegranate for your cardiovascular health
M Aviram, M Rosenblat |
Rambam Maimonides Medical Journal | 2013 |
The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate
MR Mogarekar, SS Chawhan |
Indian journal of human genetics | 2013 |
Elucidation of mechanisms of actions of thymoquinone-enriched methanolic and volatile oil extracts from Nigella sativa against cardiovascular risk parameters in experimental hyperlipidemia
S Ahmad, ZH Beg |
Lipids in Health and Disease | 2013 |
Association between paraoxonase gene and stroke in the Han Chinese population
G Zhang, W Li, Z Li, H Lv, Y Ren, R Ma, X Li, X Kang, Y Shi, Y Sun |
BMC Medical Genetics | 2013 |
The effects of atorvastatin on oxidative stress in L-NAME-treated rats
V Sozer, H Uzun, R Gelisgen, M Kaya, R Kalayci, O Tabak, N Arican, D Konukoglu |
Scandinavian Journal of Clinical & Laboratory Investigation | 2013 |
L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
V Pascale, W Pascale, V Lavanga, V Sansone, P Ferrario, VD Colonna |
Medical science monitor : international medical journal of experimental and clinical research | 2013 |
Plasma paraoxonase 1 arylesterase activity in d-galactose-induced aged rat model: correlation with LDL oxidation and redox status
D Kumar, SI Rizvi |
Aging clinical and experimental research | 2013 |
Lipoproteinemia and arylesterase activity in Zucker Fa/Fa rats fed glucomannan/spirulina-enriched squid-surimi: Glucomannan squid-surimi and cholesterolemia
M Vázquez-Velasco, L González-Torres, R Olivero-David, S Bastida, J Benedí, MI Sánchez-Reus, MJ González-Muñoz, FJ Sánchez-Muniz |
European Journal of Lipid Science and Technology | 2013 |
Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis
S Desai, SS Baker, W Liu, DA Moya, RW Browne, L Mastrandrea, RD Baker, L Zhu |
Liver International | 2013 |
Effect of the nutritional supplement ALAnerv® on the serum PON1 activity in post-acute stroke patients
BN Manolescu, M Berteanu, D Cintezã |
Pharmacological Reports | 2013 |
Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation: HDL Glycation Impairs Vasorelaxation
MC Brindisi, L Duvillard, S Monier, B Vergès, L Perségol |
Diabetes/Metabolism Research and Reviews | 2013 |
Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis
F Bayram, G Baskol, F Tanriverdi, M Baskol, D Kocer, A Caniklioğlu |
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences | 2013 |
Paraoxonase-1 Suppresses Experimental Colitis via the Inhibition of IFN- Production from CD4 T Cells
J Yamashita, C Iwamura, T Ito, M Narita, Y Hara, T Sasaki, D Masuda, M Takahashi, M Tsuchiya, K Hada, M Ishikawa, T Matsuo, Y Ohno, H Tanaka, H Maruyama, Y Ogawa, T Nakayama |
Journal of immunology (Baltimore, Md. : 1950) | 2013 |
Effect of exercise on plasma paraoxonase1 activity in rugby players: Dependance on training experience
A Otocka-Kmiecik, K Bortnik, U Szkudlarek, D Nowak, M Orłowska-Majdak |
Redox Report | 2013 |
Prognostic value of serum paraoxonase and arylesterase activity in patients with sepsis
Y Li, R Zhai, H Li, X Mei, G Qiu |
J INT MED RES | 2013 |
Effects on Transcriptional Regulation and Lipid Droplet Characteristics in the Liver of Female Juvenile Pigs after Early Postnatal Feed Restriction and Refeeding Are Dependent on Birth Weight
C Nebendahl, R Krüger, S Görs, E Albrecht, K Martens, S Hennig, N Storm, W Höppner, R Pfuhl, BU Metzler-Zebeli, HM Hammon, CC Metges, JJ Li |
PloS one | 2013 |
Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population
A Razavi, MR Baghshani, AA Rahsepar, HM Ardabili, MS Andalibi, SM Parizadeh, S Tavallaie, S Mousavi, M Ghayour-Mobarhan, G Ferns |
Annals of Clinical Biochemistry | 2013 |
Novel biological functions of high-density lipoprotein cholesterol
C Mineo, PW Shaul |
Circulation research | 2012 |
Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: Novel pathways generating dysfunctional high-density lipoprotein
M Holzer, K Zangger, D El-Gamal, V Binder, S Curcic, V Konya, R Schuligoi, A Heinemann, G Marsche |
Antioxidants & Redox Signaling | 2012 |
Psoriasis alters HDL composition and cholesterol efflux capacity
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, D El-Gamal, C Wadsack, A Heinemann, G Marsche |
Journal of lipid research | 2012 |
Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
N Martinelli, R Micaglio, L Consoli, P Guarini, E Grison, F Pizzolo, S Friso, E Trabetti, PF Pignatti, R Corrocher, O Olivieri, D Girelli |
Experimental Diabetes Research | 2012 |
Regulation of paraoxonase 1 (PON1) in PCB 126-exposed male Sprague Dawley rats
H Shen, LW Robertson, G Ludewig |
Toxicology Letters | 2012 |
Diet-Induced Weight Loss in Overweight or Obese Women and Changes in High-Density Lipoprotein Levels and Function
BO Aicher, EK Haser, LA Freeman, AV Carnie, JA Stonik, X Wang, AT Remaley, GJ Kato, RO Cannon |
Obesity | 2012 |
Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia
HK Okur, Z Pelin, M Yuksel, S Yosunkaya |
Sleep and Breathing | 2012 |
High Density Lipoprotein and it’s Dysfunction
E Eren, N Yilmaz, O Aydin |
The open biochemistry journal | 2012 |
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
J Camps, A García-Heredia, A Rull, C Alonso-Villaverde, G Aragonès, R Beltrán-Debón, E Rodríguez-Gallego, J Joven |
PPAR Research | 2012 |
Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases
N Yilmaz |
Archives of Medical Science : AMS | 2012 |
Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
R Lee, M Margaritis, KM Channon, C Antoniades |
Current medicinal chemistry | 2012 |
Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome : Oxidative stress in polycystic ovary syndrome
G Baskol, E Aygen, F Erdem, A Caniklioğlu, F Narin, Y Şahin, T Kaya |
Acta Obstetricia et Gynecologica Scandinavica | 2012 |
Association between reactive oxygen metabolites and paraoxonase 1 activity during a physical activity increase intervention with older people : d-ROMs and PON1 in physical activity
K Kotani, R Caccavello, T Mutou, T Yamada, N Taniguchi, A Gugliucci |
Australasian Journal on Ageing | 2012 |
The Past and Present of Paraoxonase Enzyme: Its Role in the Cardiovascular System and Some Diseases
S Aydin, İ Sahin, S Aydin, A Aksoy, C Citil |
Journal of Medical Biochemistry | 2012 |
Trichinella spiralis: Infection changes serum paraoxonase-1 levels, lipid profile, and oxidative status in rats
S Mido, EM Fath, AS Farid, N Nonaka, Y Oku, Y Horii |
Experimental Parasitology | 2012 |
Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies
SA Saghir, SA Khan, AT McCoy |
Critical Reviews in Toxicology | 2012 |
Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: Possible implications for cardiovascular outcomes
H Jiang, SP Stabler, RH Allen, KN Maclean |
Molecular Genetics and Metabolism | 2012 |
Impacts of some antibiotics on human serum paraoxonase 1 activity
EB Dilek, Öİ Küfrevioğlu, Ş Beydemir |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2012 |
Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis
LM Moura, S Faria, M Brito, FJ Pinto, SD Kristensen, IM Barros, N Rajamannan, F Rocha-Gonçalves |
American Journal of Cardiovascular Disease | 2012 |
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
A Otocka-Kmiecik, DP Mikhailidis, SJ Nicholls, M Davidson, J Rysz, M Banach |
Progress in Lipid Research | 2012 |
Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters
C Ertürk, MA Altay, Ş Selek, A Koçyiğit |
Scandinavian Journal of Clinical & Laboratory Investigation | 2012 |
Purification, characterization, and investigation of in vitro inhibition by metals of paraoxonase from different sheep breeds
K Erol, N Gençer, M Arslan, O Arslan |
Artificial Cells, Blood Substitutes and Biotechnology | 2012 |
The growing importance of PON1 in cardiovascular health: a review
M Macharia, MS Hassan, D Blackhurst, RT Erasmus, TE Matsha |
Journal of Cardiovascular Medicine | 2012 |
Oxidative Stress and Disease: Bioavailability and Function
A Weseler, A Bast |
Oxidative Stress and Disease | 2012 |
Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo
C Schrader, IM Ernst, H Sinnecker, ST Soukup, SE Kulling, G Rimbach |
Journal of Cellular and Molecular Medicine | 2012 |
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease
J Kotur-Stevuljević, A Peco-Antić, S Spasić, A Stefanović, D Paripović, M Kostić, D Vasić, A Vujović, Z Jelić-Ivanović, V Spasojević-Kalimanovska, D Kornic-Ristovski |
Pediatric Nephrology | 2012 |
R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke
A Mahrooz, G Gohari, MB Hashemi, M Zargari, H Musavi, M Abedini, A Alizadeh |
Molecular Biology Reports | 2012 |
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease
AC Belin, C Ran, A Anvret, S Paddock, M Westerlund, A Håkansson, H Nissbrandt, P Söderkvist, N Dizdar, A Ahmadi, M Anvret, T Willows, O Sydow, D Galter |
Neuroscience Letters | 2012 |
Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis
SM Olama, MM Elarman |
Rheumatology International | 2012 |
Synthesis and paroxonase activities of novel bromophenols
Y Akbaba, C Türkeş, L Polat, H Söyüt, E Şahin, A Menzek, S Göksu, Ş Beydemir |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2012 |
HDL functionality:
H Soran, S Hama, R Yadav, PN Durrington |
Current Opinion in Lipidology | 2012 |
Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction
F Bayram, D Kocer, M Ozsan, S Muhtaroglu |
Gynecological Endocrinology | 2012 |
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
H Murakami, J Tanabe, N Tamasawa, K Matsumura, M Yamashita, K Matsuki, H Murakami, J Matsui, T Suda |
Diabetes Research and Clinical Practice | 2012 |
Hypolipidemic and antioxidant activities of thymoquinone and limonene in atherogenic suspension fed rats
S Ahmad, ZH Beg |
Food Chemistry | 2012 |
The Antioxidant Status Response to Low-Fat and Walnut Paste–Enriched Meat Differs in Volunteers at High Cardiovascular Risk Carrying Different PON-1 Polymorphisms
FJ Sánchez-Muniz, A Canales, M Nus, S Bastida, M Guillén, D Corella, B Olmedilla-Alonso, F Granado-Lorencio, J Benedí |
Journal of the American College of Nutrition | 2012 |
Psoriasis alters HDL composition and cholesterol efflux capacity[S]
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, D El-Gamal, C Wadsack, A Heinemann, G Marsche |
Journal of lipid research | 2012 |
Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: relationship with low density lipoprotein oxidation
PR Augusti, AR Ruviaro, A Quatrin, S Somacal, GM Conterato, JT Vicentini, MM Duarte, T Emanuelli |
Lipids in Health and Disease | 2012 |
Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases
D Litvinov, H Mahini, M Garelnabi |
North American Journal of Medical Sciences | 2012 |
Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism
A Santi, MM Duarte, CC de Menezes, VL Loro |
International Journal of Endocrinology | 2012 |
Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
K Ishikawa, M Navab, AJ Lusis |
International Journal of Hypertension | 2012 |
Regulation of Hepatic Paraoxonase-1 Expression
B Fuhrman |
Journal of Lipids | 2012 |
Paraoxonase 1 in Chronic Kidney Failure
A Gugliucci, K Kotani, S Kimura |
Journal of Lipids | 2012 |
Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease
O Hussein, J Zidan, KA Jabal, I Shams, S Szvalb, M Grozovski, I Bersudsky, R Karry, M Aviram |
International Journal of Hepatology | 2012 |
Paraoxonase 1 Polymorphism and Prenatal Pesticide Exposure Associated with Adverse Cardiovascular Risk Profiles at School Age
HR Andersen, C Wohlfahrt-Veje, C Dalgård, L Christiansen, KM Main, C Nellemann, K Murata, TK Jensen, NE Skakkebæk, P Grandjean, D Amre |
PloS one | 2012 |
Paraoxonase-1 Gene Q192R Polymorphism and Reactive Oxygen Metabolites
K Kotani, K Tsuzaki, N Sakane |
J INT MED RES | 2012 |
Inflammation, paraoxonase-1 activity and HDL physico-chemical properties: a comparison between Prader-Willi syndrome and obese subjects
G Ferretti, T Bacchetti, S Masciangelo, G Grugni, V Bicchiega |
Disease models & mechanisms | 2012 |
Blood pressure, lipid levels and apolipoprotein A1 and paraoxonase 1 gene polymorphisms in patients with abdominal obesity
, OO Bolshakova, OD Belyaeva, OA Berkovich, VI Larionova, EI Baranova |
2012 | |
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler, Kathrin Heinrich, Lucia Rohrer, Carola Doerries, Meliana Riwanto, Diana M. Shih, Angeliki Chroni, Keiko Yonekawa, Sokrates Stein, Nicola Schaefer, Maja Mueller, Alexander Akhmedov, Georgios Daniil, Costantina Manes, Christian Templin, Christophe Wyss, Willibald Maier, Felix C. Tanner, Christian M. Matter, Roberto Corti, Clement E. Furlong, Aldons J. Lusis, Arnold von Eckardstein, Alan M. Fogelman, Thomas F. Lüscher, Ulf Landmesser |
Journal of Clinical Investigation | 2011 |
Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo
T Hara, T Ishida, Y Kojima, H Tanaka, T Yasuda, M Shinohara, R Toh, K Hirata |
Journal of lipid research | 2011 |
Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis
JA Farmer, J Liao |
Current Atherosclerosis Reports | 2011 |
Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates
E Gesteiro, S Bastida, M Vázquez-Velasco, D Corella, M Guillén, JM Ordovas, FJ Sánchez-Muniz |
European Journal of Pediatrics | 2011 |
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff |
Herbal Medicine | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Effects of Nori- and Wakame-enriched meats with or without supplementary cholesterol on arylesterase activity, lipaemia and lipoproteinaemia in growing Wistar rats
R Olivero-David, A Schultz-Moreira, M Vázquez-Velasco, L González-Torres, S Bastida, J Benedí, MI Sanchez-Reus, MJ González-Muñoz, FJ Sánchez-Muniz |
British Journal of Nutrition | 2011 |
Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease
A Vaisi-Raygani, H Ghaneialvar, Z Rahimi, H Tavilani, T Pourmotabbed, E Shakiba, A Vaisi-Raygani, A Kiani, M Aminian, R Alibakhshi, C Bartels |
Molecular Biology Reports | 2011 |
Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease
A Vaisi-Raygani, Z Rahimi, H Tavilani, H Vaisi-Raygani, A Kiani, M Aminian, E Shakiba, Y Shakiba, T Pourmotabbed |
Molecular Biology Reports | 2011 |
Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients
S Michalak, R Kazmierski, A Hellmann, E Wysocka, D Kocialkowska-Adamczewska, A Wencel-Warot, WL Nowinski |
Cerebrovascular Diseases | 2011 |
Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction
M Aldemir, E Okulu, S Neşelioğlu, O Erel, K Ener, Ö Kayıgil |
Andrologia | 2011 |
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia
AP Agouridis, V Tsimihodimos, TD Filippatos, AA Dimitriou, CC Tellis, MS Elisaf, DP Mikhailidis, AD Tselepis |
Expert Opinion on Pharmacotherapy | 2011 |
Pomegranate juice increases levels of paraoxonase1 (PON1) expression and enzymatic activity in streptozotocin-induced diabetic mice fed with a high-fat diet
G Betanzos-Cabrera, JA Guerrero-Solano, MM Martínez-Pérez, ZG Calderón-Ramos, H Belefant-Miller, JC Cancino-Diaz |
Food Research International | 2011 |
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
ED Sezer, EY Sozmen, D Nart, T Onat |
Vascular Health and Risk Management | 2011 |
Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2
AE Wagner, C Boesch-Saadatmandi, D Breckwoldt, C Schrader, C Schmelzer, F Döring, K Hashida, O Hori, S Matsugo, G Rimbach |
BMC complementary and alternative medicine | 2011 |
The three-gene paraoxonase family: Physiologic roles, actions and regulation
LP Précourt, D Amre, MC Denis, JC Lavoie, E Delvin, E Seidman, E Levy |
Atherosclerosis | 2011 |
The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release
M Koren-Gluzer, M Aviram, E Meilin, T Hayek |
Atherosclerosis | 2011 |
Association of L55M and Q192R Polymorphisms of Paraoxonase-1 Gene with Preeclampsia
M Yaghmaei, M Hashemi, A Azarian, A Moazeni-Roodi, M Mokhtari, A Naghavai, S Salimi, M Mohammadi, M Taheri, S Ghavami |
Archives of Medical Research | 2011 |
Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene
A Ezzaher, DH Mouhamed, A Mechri, F Neffati, J Rejeb, A Omezzine, W Douki, A Bouslama, L Gaha, MF Najjar |
Journal of Affective Disorders | 2011 |
Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case–control studies
M Wang, X Lang, L Zou, S Huang, Z Xu |
Atherosclerosis | 2011 |
Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine
S Yıldırım, S Akar, M Kuyucu, A Yıldırım, Ş Dane, R Aygül |
Cell Biochemistry and Function | 2011 |
Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion
H Tavori, M Aviram, S Khatib, R Musa, D Mannheim, R Karmeli, J Vaya |
Free radical biology & medicine | 2011 |
Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patients
Y Wang, AO Luk, RC Ma, WY So, CH Tam, MC Ng, X Yang, V Lam, PC Tong, JC Chan |
Nephrology Dialysis Transplantation | 2011 |
Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells
CC Cheng, CM Hsueh, KW Liang, CT Ting, CL Wen, SL Hsu |
European Journal of Pharmacology | 2011 |
Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs
N Yilmaz, O Aydin, A Yegin, A Tiltak, E Eren |
Clinical Biochemistry | 2011 |
Hemodynamics and Metabolism at Low versus Moderate Altitudes
AC de León, MC Pérez, DA González, BB Díaz, SD Coello, AG Hernández, AA C |
High Altitude Medicine & Biology | 2011 |
Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation
M Rosenblat, N Volkova, J Ward, M Aviram |
Atherosclerosis | 2011 |
Polyphenols and Human Health: A Prospectus
F Visioli, CA de la Lastra, C Andres-Lacueva, M Aviram, C Calhau, A Cassano, M D’Archivio, A Faria, G Favé, V Fogliano, R Llorach, P Vitaglione, M Zoratti, M Edeas |
Critical Reviews in Food Science and Nutrition | 2011 |
Semen Traits and Seminal Plasma Biochemical Parameters in White Leghorn Layer Breeders
RU Khan, V Laudadio, V Tufarelli |
Reproduction in Domestic Animals | 2011 |
Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity
XQ Tang, YK Ren, RQ Chen, YY Zhuang, HR Fang, JH Xu, CY Wang, B Hu |
Clinical and Experimental Pharmacology and Physiology | 2011 |
Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study
A Mahrooz, MR Rashidi, M Nouri |
Journal of Clinical Laboratory Analysis | 2011 |
<i>In vitro</i> efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity
M Arslan, N Gencer, O Arslan, OO Guler |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2011 |
Paraoxonase-1, an organophosphate detoxifier and cardioprotective enzyme, is inhibited by anesthetics: An in vitro and in vivo insight
M Şentürk, D Ekinci, HA Alıcı, Ş Beydemir |
Pesticide Biochemistry and Physiology | 2011 |
Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies
Y Zhao, Y Ma, Y Fang, L Liu, S Wu, D Fu, X Wang |
Molecular Genetics and Metabolism | 2011 |
Autoimmune-Mediated Reduction of High-Density Lipoprotein-Cholesterol and Paraoxonase-1 Activity in SLE-Prone gld Mice
R Srivastava, S Yu, BW Parks, LL Black, JH Kabarowski |
Arthritis & Rheumatism | 2011 |
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy
N Nezami, A Ghorbanihaghjo, H Argani, J Safa, N Rashtchizadeh, AM Vatankhah, B Salari, B Hajhosseini |
Clinical Biochemistry | 2011 |
Effect of dietary lipids on paraoxonase-1 activity and gene expression
G Ferretti, T Bacchetti |
Nutrition Metabolism and Cardiovascular Diseases | 2011 |
Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
M Rosenblat, N Volkova, M Aviram |
BioFactors | 2011 |
Lipid status, paraoxonase-1 activity and metabolic parameters in serum of heifers and lactating cows related to oxidative stress
M Antončić-Svetina, R Turk, A Svetina, D Gereš, B Rekić, D Juretić |
Research in Veterinary Science | 2011 |
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis
ZG She, HZ Chen, Y Yan, H Li, DP Liu |
Antioxidants & Redox Signaling | 2011 |
Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats
T Ghaffari, M Nouri, E Irannejad, MR Rashidi |
BioImpacts : BI | 2011 |
HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women
T Gaillard, S Parthasarathy, K Osei |
Diabetes care | 2011 |
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation
DM Olszewska-Słonina, D Mątewski, R Czajkowski, KJ Olszewski, A Woźniak, G Odrowąż-Sypniewska, K Lis, D Musiałkiewicz, B Kowaliszyn |
Medical science monitor : international medical journal of experimental and clinical research | 2011 |
Effects of exercise intensity on HDL-C subparticles and atherogenic index
성기운, S Kim, YS Lee |
Exercise Science | 2011 |
Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients
Arun Kumar, Utpal Kumar Biswas |
Heart Asia | 2011 |
Pleiotropic Effects of Thyroid Hormones: Learning from Hypothyroidism
M Franco, E Chávez, O Pérez-Méndez |
Journal of Thyroid Research | 2011 |
The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients
D Altuner, I Ates, SH Suzen, GV Koc, Y Aral, A Karakaya |
Toxicology and industrial health | 2011 |
Serum Levels of Lipids, Lipoproteins and Paraoxonase Activity in Pre-Eclampsia
B Demir, S Demir, Y Atamer, S Guven, A Atamer, Y Kocyigit, A Hekimoglu, G Toprak |
J INT MED RES | 2011 |
Nitric oxide and oxidative stress in vascular disease
U Förstermann |
Pflügers Archiv - European Journal of Physiology | 2010 |
Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia
S Unchern, N Laohareungpanya, Y Sanvarinda, K Pattanapanyasat, P Tanratana, U Chantharaksri, N Sibmooh |
Lipids | 2010 |
Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis
I Banerjee |
European Journal of Epidemiology | 2010 |
The genetics of vascular complications in diabetes mellitus
D Farbstein, AP Levy |
Cardiology Clinics | 2010 |
Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development
H Tavori, M Rosenblat, J Vaya, M Aviram |
Clinical Lipidology | 2010 |
Genetic Association Between Single Nucleotide Polymorphisms in the Paraoxonase 1 (PON1) Gene and Small-for-Gestational-Age Birth in Related and Unrelated Subjects
C Infante-Rivard |
American Journal of Epidemiology | 2010 |
Paraoxonase: Its antiatherogenic role in chronic renal failure
M Prakash, NM Phani, R Kavya, M Supriya |
Indian journal of nephrology | 2010 |
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
A Zafiropoulos, M Linardakis, EH Jansen, AM Tsatsakis, A Kafatos, GN Tzanakakis |
Journal of lipid research | 2010 |
Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression
S Ahmad, JE Scott |
Biochemical and Biophysical Research Communications | 2010 |
A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity
S Ahmad, JJ Carter, JE Scott |
Analytical Biochemistry | 2010 |
Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy
S Singh, S Dhingra, DD Ramdath, S Vasdev, V Gill, PK Singal |
Journal of Cardiovascular Translational Research | 2010 |
An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats
AS Farid, S Mido, BK Linh, T Hayashi, Y Horii |
European Journal of Clinical Investigation | 2010 |
Betaine Protects Chronic Alcohol and ω-3 PUFA-Mediated Down-Regulations of PON1 Gene, Serum PON1 and Homocysteine Thiolactonase Activities With Restoration of Liver GSH
R Varatharajalu, M Garige, LC Leckey, M Gong, MR Lakshman |
Alcoholism, clinical and experimental research | 2010 |
Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions
S Yamashita, K Tsubakio-Yamamoto, T Ohama, Y Nakagawa-Toyama, M Nishida |
Journal of Atherosclerosis and Thrombosis | 2010 |
Effect of single bout of maximal excercise on plasma antioxidant status and paraoxonase activity in young sportsmen
A Otocka-Kmiecik, M Lewandowski, R Stolarek, U Szkudlarek, D Nowak, M Orlowska-Majdak |
Redox Report | 2010 |
Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods
S Barathi, M Charanya, S Muthukumaran, N Angayarkanni, V Umashankar |
Journal of Ocular Biology, Diseases, and Informatics | 2010 |
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice
C Zhang, W Peng, M Wang, J Zhu, Y Zang, W Shi, J Zhang, J Qin |
Gene Therapy | 2010 |
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
PP Toth, MH Davidson |
Journal of Clinical Lipidology | 2010 |
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis
B Fuhrman, A Gantman, M Aviram |
Atherosclerosis | 2010 |
Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice
C Boesch-Saadatmandi, J Niering, AM Minihane, I Wiswedel, A Gardeman, S Wolffram, G Rimbach |
Atherosclerosis | 2010 |
Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-γ pathway
J Khateeb, A Gantman, AJ Kreitenberg, M Aviram, B Fuhrman |
Atherosclerosis | 2010 |
Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients
B Fuhrman, N Volkova, M Aviram |
Nutrition | 2010 |
Purification and kinetic properties of rabbit liver paraoxonase 1
T Bayrak, A Bayrak, E Demirpençe, K Kılınç |
Journal of Chromatography B | 2010 |
Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum
MM İşgör, Ş Beydemir |
European Journal of Pharmacology | 2010 |
Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon
EG Duysen, K Parikh, V Aleti, V Manne, O Lockridge, N Chilukuri |
Gene Therapy | 2010 |
Consumption of polyphenolic-rich beverages (mostly pomegranate and black currant juices) by healthy subjects for a short term increased serum antioxidant status, and the serum’s ability to attenuate macrophage cholesterol accumulation
M Rosenblat, N Volkova, J Attias, R Mahamid, M Aviram |
Food & Function | 2010 |
Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors
M Vázquez-Velasco, LE Díaz, R Lucas, S Gómez-Martínez, S Bastida, A Marcos, FJ Sánchez-Muniz |
British Journal of Nutrition | 2010 |
Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: Comparison with clofibrate
EY Kwon, GM Do, YY Cho, YB Park, SM Jeon, MS Choi |
Food and Chemical Toxicology | 2010 |
Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia
AD Tselepis, G Hahalis, CC Tellis, EC Papavasiliou, PT Mylona, A Kourakli, DC Alexopoulos |
Journal of lipid research | 2010 |
Quercetin & Ethanol Attenuate the Progression of Atherosclerotic Plaques with Concomitant Up Regulation of Paraoxonase1 (PON1) Gene Expression and PON1 Activity in LDLR-/- Mice
LC Leckey, M Garige, R Varatharajalu, M Gong, T Nagata, CF Spurney, RM Lakshman |
Alcoholism, clinical and experimental research | 2010 |
Low Plasma Hdl Cholesterol and Elevated C Reactive Protein further Increase Cardiovascular Disease Risk in Latinos with Type 2 Diabetes
MC Calle, S Vega-López, S Segura-Pérez, JS Volek, R Pérez-Escamilla, ML Fernandez |
Journal of diabetes & metabolism | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis
M Hashemi, AK Moazeni-Roodi, A Fazaeli, M Sandoughi, M Taheri, GR Bardestani, Z Zakeri, DM Kordi-Tamandani, S Ghavami |
Genetics and Molecular Research | 2010 |
Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran
M Hashemi, AK Moazeni-Roodi, A Fazaeli, M Sandoughi, GR Bardestani, DM Kordi-Tamandani, S Ghavami |
Genetics and Molecular Research | 2010 |
Frying of Food: Oxidation, Nutrient and Non-Nutrient Antioxidants, Biologically Active Compounds and High Temperatures, Second Edition
F Snchez-Muniz, J Benedi, S Bastida, R Olivero-David |
Frying of Food: Oxidation, Nutrient and Non-Nutrient Antioxidants, Biologically Active Compounds and High Temperatures, Second Edition | 2010 |
The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study
A Gluba, T Pietrucha, M Banach, G Piotrowski, J Rysz |
Angiology | 2010 |
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
EJ Calabrese, MP Mattson, V Calabrese |
Human & Experimental Toxicology | 2010 |
Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo
T Hara, T Ishida, Y Kojima, H Tanaka, T Yasuda, M Shinohara, R Toh, K Hirata |
Journal of lipid research | 2010 |
Plasma levels of lipoprotein-associated phospholipase A 2 are increased in patients with β-thalassemia
AD Tselepis, G Hahalis, CC Tellis, EC Papavasiliou, PT Mylona, A Kourakli, DC Alexopoulos |
Journal of lipid research | 2010 |
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
A Zafiropoulos, M Linardakis, EH Jansen, AM Tsatsakis, A Kafatos, GN Tzanakakis |
Journal of lipid research | 2010 |
Asymptomatic Atherosclerosis
M Naghavi |
2010 | |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Oxidative risk for atherothrombotic cardiovascular disease
JA Leopold, J Loscalzo |
Free radical biology & medicine | 2009 |
Is alcohol beneficial or harmful for cardioprotection?
R Lakshman, M Garige, M Gong, L Leckey, R Varatharajalu, S Zakhari |
Genes & Nutrition | 2009 |
Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat
G Lacraz, MH Giroix, N Kassis, J Coulaud, A Galinier, C Noll, M Cornut, F Schmidlin, JL Paul, N Janel, JC Irminger, M Kergoat, B Portha, MY Donath, JA Ehses, F Homo-Delarche, K Maedler |
PloS one | 2009 |
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
J Camps, J Marsillach, J Joven |
World journal of gastroenterology : WJG | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
The roles of PON1 and PON2 in cardiovascular disease and innate immunity
DM Shih, AJ Lusis |
Current Opinion in Lipidology | 2009 |
The paraoxonases: role in human diseases and methodological difficulties in measurement
J Camps, J Marsillach, J Joven |
Critical Reviews in Clinical Laboratory Sciences | 2009 |
Autism
H Jyonouchi |
Autism | 2009 |
The paraoxonase gene family and atherosclerosis
D Seo, P Goldschmidt-Clermont |
Current Atherosclerosis Reports | 2009 |
Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease
JJ Regieli, JW Jukema, PA Doevendans, AH Zwinderman, JJ Kastelein, DE Grobbee, Y der Graaf |
Journal of the American College of Cardiology | 2009 |
Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene
S Xie, J Li, Y Chen, C Wang, H Zhang, D Mo |
Molecular Biology Reports | 2009 |
Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality
YT Liao, WF Li, CJ Chen, RJ Prineas, WJ Chen, ZM Zhang, CW Sun, SL Wang |
Toxicology and Applied Pharmacology | 2009 |
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer
H Camuzcuoglu, DT Arioz, H Toy, S Kurt, H Celik, O Erel |
Gynecologic Oncology | 2009 |
Decreased Paraoxonase and Arylesterase Activities in the Pathogenesis of Future Atherosclerotic Heart Disease in Women with Gestational Diabetes Mellitus
H Camuzcuoglu, H Toy, H Cakir, H Celik, O Erel |
Journal of Women's Health | 2009 |
Variation in paraoxonase-1 activity and atherosclerosis
H Soran, NN Younis, V Charlton-Menys, P Durrington |
Current Opinion in Lipidology | 2009 |
Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity
G Ginsberg, P Neafsey, D Hattis, KZ Guyton, DO Johns, B Sonawane |
Journal of Toxicology and Environmental Health, Part B | 2009 |
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population
BC DemirdögÌen, SÌ Demirkaya, A TürkanogÌlu, S Bek, E Arınç, O Adalı |
Cell Biochemistry and Function | 2009 |
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes
L Gaidukov, D Bar, S Yacobson, E Naftali, O Kaufman, R Tabakman, DS Tawfik, E Levy-Nissenbaum |
BMC clinical pharmacology | 2009 |
Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans
F Thameem, X He, VS Voruganti, SD Nath, P Fanti, J Blangero, JW Maccluer, AG Comuzzie, NH Arar, HE Abboud |
Kidney & blood pressure research | 2009 |
Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation
HD Kaur, MP Bansal |
Lipids in Health and Disease | 2009 |
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects
H Tavori, M Aviram, S Khatib, R Musa, S Nitecki, A Hoffman, J Vaya |
Free radical biology & medicine | 2009 |
Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: In vitro and in vivo studies
M Efrat, M Rosenblat, S Mahmood, J Vaya, M Aviram |
Atherosclerosis | 2009 |
Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum
H Aksoy, AN Aksoy, A Ozkan, H Polat |
Journal of Clinical Laboratory Analysis | 2009 |
Involvement of paraoxonase 1 genetic variants in Alzheimer���s disease neuropathology
V Leduc, L Th��roux, D Dea, Y Robitaille, J Poirier |
European Journal of Neuroscience | 2009 |
Paraoxonase: A multifaceted biomolecule
B Goswami, D Tayal, N Gupta, V Mallika |
Clinica Chimica Acta | 2009 |
Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides
AM Tsatsakis, A Zafiropoulos, MN Tzatzarakis, GN Tzanakakis, A Kafatos |
Toxicology Letters | 2009 |
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL
MK Muellner, SM Schreier, H Laggner, M Hermann, H Esterbauer, M Exner, BM Gmeiner, S Kapiotis |
Biochemical Journal | 2009 |
Purification of PON1 from Human Serum and Assessment of Enzyme Kinetics Against Metal Toxicity
D Ekinci, Ş Beydemir |
Biological Trace Element Research | 2009 |
Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells
K Arii, T Suehiro, K Ota, Y Ikeda, Y Kumon, F Osaki, M Inoue, S Inada, N Ogami, H Takata, K Hashimoto, Y Terada |
Atherosclerosis | 2009 |
Grapes, Wines, Resveratrol, and Heart Health
AA Bertelli, DK Das |
Journal of Cardiovascular Pharmacology | 2009 |
Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates
E Carreón-Torres, K Rendón-Sauer, M Monter-Garrido, P Toledo-Ibelles, R Gamboa, M Menjivar, R López-Marure, G Luc, C Fievet, D Cruz, G Vargas-Alarcón, O Pérez-Méndez |
Clinica Chimica Acta | 2009 |
Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals
N Gençer, O Arslan |
Journal of Chromatography B | 2009 |
Current understanding of the mechanisms involved in metabolic detoxification of warfare nerve agents
M Jokanović |
Toxicology Letters | 2009 |
Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy
C Li, Q Gu |
Nephrology | 2009 |
Paraoxonases role in the prevention of cardiovascular diseases
M Rosenblat, M Aviram |
BioFactors | 2009 |
Altered Flow-Mediated Vasodilatation, Low Paraoxonase-1 Activity, and Abnormal High-Density Lipoprotein Subclass Distribution in Takayasu's Arteritis
N Espinola-Zavaleta, ME Soto-López, E Carreón-Torres, R Gamboa, AM Mejía, R Márquez-Velasco, R Bojalil, C Huesca-Gomez, PA Reyes, O Pérez-Méndez |
Circulation Journal | 2009 |
Expression and activity of paraoxonase 1 in human cataractous lens tissue
Z Hashim, A Ilyas, A Saleem, A Salim, S Zarina |
Free radical biology & medicine | 2009 |
Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases
D Ekinci, Ş Beydemir |
European Journal of Pharmacology | 2009 |
Is Plasma Homocysteine Level Associated With Metabolic Syndrome Components in Adolescents?
NB Ph.D., CY M.D., AÖ Ph.D., FB M.D., MM M.D., SK M.D. |
Metabolic Syndrome and Related Disorders | 2009 |
Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries
M Najafi, LH Gohari, M Firoozrai |
Thrombosis Research | 2009 |
Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity
S Motta, C Letellier, M Ropert, C Motta, JJ Thiébault |
The Veterinary Journal | 2009 |
Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs
M Kasprzak, M Iskra, W Majewski, T Wielkoszyński |
Clinical Biochemistry | 2009 |
Schistosoma mansoni: Effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel
MM Helmy, SS Mahmoud, ZH Fahmy |
Experimental Parasitology | 2009 |
Handbook of Toxicology of Chemical Warfare Agents
DR Varma, S Mulay, S Chemtob |
Handbook of Toxicology of Chemical Warfare Agents | 2009 |
Homocysteine and lipids: S-Adenosyl methionine as a key intermediate
R Obeid, W Herrmann |
FEBS Letters | 2009 |
Anti-ulcer Activity of Curcumin on Experimental Gastric Ulcer in Rats and Its Effect on Oxidative Stress/Antioxidant, IL-6 and Enzyme Activities
M Tuorkey, K Karolin |
Biomedical and Environmental Sciences | 2009 |
Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status
A Nagila, T Permpongpaiboon, S Tantrarongroj, P Porapakkham, K Chinwattana, S Deakin, S Porntadavity |
Pharmacological Reports | 2009 |
Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study
RS Birjmohun, M Vergeer, ES Stroes, MS Sandhu, SL Ricketts, MW Tanck, NJ Wareham, JW Jukema, JJ Kastelein, KT Khaw, SM Boekholdt, F Kronenberg |
PloS one | 2009 |
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
J Camps, J Marsillach, J Joven |
World journal of gastroenterology : WJG | 2009 |
Q192R and L55M polymorphism in paraoxonase 1 gene in patients with coronary heart disease of different age and sex
GD Perales, AN Voitovich, MA Bogdanova, AY Anisenkova, MI Badmaeva, VL Stepanova, BI Smirnov, TN Ryabkova, VV Isakov, SI Yagashkina, ON Semenova, DV Cherkashin, SA Boitsov, YR Kovalev, OA Berkovich, EV Shlyakhto, NV Kirillova, VI Larionova |
2009 | |
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
O Rozenberg, M Shiner, M Aviram, T Hayek |
Free radical biology & medicine | 2008 |
Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice
C Noll, J Hamelet, E Matulewicz, JL Paul, JM Delabar, N Janel |
The Journal of Nutritional Biochemistry | 2008 |
Laboratory Assessment of HDL Heterogeneity and Function
R Movva, DJ Rader |
Clinical chemistry | 2008 |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Advanced Protocols in Oxidative Stress I
D Armstrong |
2008 | |
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield |
2008 | |
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield |
2008 | |
The Influence of PON1 192 Polymorphism on Endothelial Function in Diabetic Subjects with or without Hypertension
C IRACE, C CORTESE, E FIASCHI, F SCAVELLI, L LIBERATOSCIOLI, G FEDERICI, A GNASSO |
Hypertension Research | 2008 |
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies
U Förstermann |
Nature Clinical Practice Cardiovascular Medicine | 2008 |
Relationship of adiponectin to serum paraoxonase 1
L Bajnok, E Csongradi, I Seres, Z Varga, S Jeges, A Peti, Z Karanyi, A Juhasz, E Mezosi, EV Nagy, G Paragh |
Atherosclerosis | 2008 |
Association of paraoxonase activity and coronary blood flow
A Yildiz, M Gur, R Yilmaz, R Demirbag, M Polat, S Selek, H Celik, O Erel |
Atherosclerosis | 2008 |
High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain
C Garcés, L López-Simón, R Rubio, M Benavente, B Cano, H Ortega, M Oya |
Clinical Chemistry and Laboratory Medicine | 2008 |
Effect of Atorvastatin on Paraoxonase Activity in Patients with Hyperlipidemia
JK Shetty, M Prakash, S Tripathy, M Verma, P Vikram |
Asian Journal of Biochemistry | 2008 |
Lipid peroxidation in stroke patients
G Ferretti, T Bacchetti, S Masciangelo, L Nanetti, L Mazzanti, M Silvestrini, M Bartolini, L Provinciali |
Clinical Chemistry and Laboratory Medicine | 2008 |
Association of paraoxonase activity and coronary collateral flow
A Yildiz, Y Sezen, M Gur, R Yilmaz, R Demirbag, O Erel |
Coronary Artery Disease | 2008 |
Paraoxonase 1: Genetics and Activities During Aging
F Marchegiani, M Marra, F Olivieri, M Cardelli, RW James, M Boemi, C Franceschi |
Rejuvenation Research | 2008 |
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress
Y Liu, B Mackness, M Mackness |
Free radical biology & medicine | 2008 |
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma
G Lurie, LR Wilkens, PJ Thompson, KE McDuffie, ME Carney, KY Terada, MT Goodman |
Cancer epidemiology, biomarkers & prevention | 2008 |
Determination of paraoxonase 1 status without the use of toxic organophosphate substrates
RJ Richter, GP Jarvik, CE Furlong |
Circulation. Cardiovascular genetics | 2008 |
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin
P Jaichander, K Selvarajan, M Garelnabi, S Parthasarathy |
Journal of lipid research | 2008 |
Paraoxonase (PON1) is associated with familial combined hyperlipidemia
TM van Himbergen, LJ van Tits, E Avest, M Roest, HA Voorbij, J Graaf, AF Stalenhoef |
Atherosclerosis | 2008 |
Small dense LDL oxidation in hypertensives and diabetics and prediction of Metabolic Syndrome
J Nishtha, I Naseem, J Ahmad |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2008 |
The paraoxonase gene polymorphism in stroke patients and lipid profile
BS Shin, SY Oh, YS Kim, KW Kim |
Acta Neurologica Scandinavica | 2008 |
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
GM Do, EY Kwon, HJ Kim, SM Jeon, TY Ha, T Park, MS Choi |
Biochemical and Biophysical Research Communications | 2008 |
Macrophage paraoxonase 1 (PON1) binding sites
M Efrat, M Aviram |
Biochemical and Biophysical Research Communications | 2008 |
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
G Weijun, L Juming, Y Guoqing, D Jingtao, G Qinghua, M Yiming, P Changyu |
Advances in Therapy | 2008 |
The ontogeny of drug metabolism enzymes and implications for adverse drug events
RN Hines |
Pharmacology & Therapeutics | 2008 |
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study
JA Troughton, JV Woodside, JW Yarnell, D Arveiler, P Amouyel, J Ferrières, P Ducimetière, CC Patterson, G Luc |
Atherosclerosis | 2008 |
Determination of rat and mice arylesterase activity using serum mimetics
M Nus, FJ Sánchez-Muniz, JV Gago, E López-Oliva, JM Sánchez-Montero |
Enzyme and microbial technology | 2008 |
Pharmacologic Management of Isolated Low High-Density Lipoprotein Syndrome
V Bermúdez, R Cano, C Cano, F Bermúdez, N Arraiz, L Acosta, F Finol, MR Pabón, A Amell, N Reyna, J Hidalgo, P Kendall, V Manuel, R Hernández |
American Journal of Therapeutics | 2008 |
Purification of Human Serum Paraoxonase and Effect of Acetylsalicylic Acid on Paraoxonase Activity
N Demir, H Nadaroğlu, Y Demir |
Pharmaceutical Biology | 2008 |
Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamsters
EM Jang, MS Choi, UJ Jung, MJ Kim, HJ Kim, SM Jeon, SK Shin, CN Seong, MK Lee |
Metabolism | 2008 |
Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model
A Jafarnejad, SZ Bathaie, M Nakhjavani, MZ Hassan |
Life Sciences | 2008 |
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients
J Kotur-Stevuljevic, S Spasic, Z Jelic-Ivanovic, V Spasojevic-Kalimanovska, A Stefanovic, A Vujovic, L Memon, D Kalimanovska-Ostric |
Clinical Biochemistry | 2008 |
Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients
A Yildiz, M Gur, R Demirbag, R Yilmaz, S Akyol, M Aslan, O Erel |
Clinical Biochemistry | 2008 |
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate
M Koitka, J Höchel, D Obst, A Rottmann, H Gieschen, HH Borchert |
Analytical Biochemistry | 2008 |
Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats
M Silva, ME Silva, H Paula, CM Carneiro, ML Pedrosa |
Nutrition Research | 2008 |
Paraoxonase 1 activities and polymorphisms in autism spectrum disorders
SP Paşca, E Dronca, B Nemeş, T Kaucsár, E Endreffy, F Iftene, I Benga, R Cornean, M Dronca |
Journal of Cellular and Molecular Medicine | 2008 |
Paraoxonase and Arylesterase Activities in Patients with Preeclampsia
Ayse Nur Aksoy, Nurinnisa Ozturk, Hulya Aksoy, Fatih Akcay |
The Eurasian Journal of Medicine | 2008 |
A common haplotype within the PON1 promoter region is associated with sporadic ALS
JE Landers, L Shi, TJ Cho, JD Glass, CE Shaw, PN Leigh, F Diekstra, M Polak, I Rodriguez-Leyva, S Niemann, BJ Traynor, D Mckenna-Yasek, PC Sapp, A Al-Chalabi, AM Wills, RH Brown |
Amyotrophic Lateral Sclerosis | 2008 |
Effects of Origanum onites on Endothelial Function and Serum Biochemical Markers in Hyperlipidaemic Patients
B Özdemir, A Ekbul, NB Topal, E Sarandöl, S Sağ, KH Başer, J Cordan, S Güllülü, E Tuncel, İ Baran, A Aydinlar |
J INT MED RES | 2008 |
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin
P Jaichander, K Selvarajan, M Garelnabi, S Parthasarathy |
Journal of lipid research | 2008 |
The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism
B Mackness, M Mackness, M Aviram, G Paragh |
2008 | |
Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux
M Rosenblat, N Volkova, R Coleman, Y Almagor, M Aviram |
The Journal of Nutritional Biochemistry | 2008 |
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield |
2008 | |
Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma
G Lurie, LR Wilkens, PJ Thompson, KE McDuffie, ME Carney, KY Terada, MT Goodman |
Cancer epidemiology, biomarkers & prevention | 2008 |
Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity
AT Shamshiev, F Ampenberger, B Ernst, L Rohrer, BJ Marsland, M Kopf |
Journal of Experimental Medicine | 2007 |
Cholinergic status modulations in human volunteers under acute inflammation
K Ofek, KS Krabbe, T Evron, M Debecco, AR Nielsen, H Brunnsgaad, R Yirmiya, H Soreq, BK Pedersen |
Journal of Molecular Medicine | 2007 |
Decreased Obesity and Atherosclerosis in Human Paraoxonase 3 Transgenic Mice
DM Shih, YR Xia, XP Wang, SS Wang, N Bourquard, AM Fogelman, AJ Lusis, ST Reddy |
Circulation research | 2007 |
Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis
CJ Carter |
Neurochemistry International | 2007 |
Paraoxonase activity in patients with erectile dysfunction
H Ciftci, E Yeni, M Savas, A Verit, H Celik |
International Journal of Impotence Research | 2007 |
High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench
Y Levy |
Cardiovascular Research | 2007 |
Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia
M Aslan, M Kosecik, M Horoz, S Selek, H Celik, O Erel |
Atherosclerosis | 2007 |
Ingestion of moderately thermally oxidized polyunsaturated fat decreases serum resistance to oxidation in men with coronary artery disease
WH Sutherland, MJ Williams, SA de Jong, MP McCormick |
Nutrition Research | 2007 |
Frequency of Paraoxonase 192/55 Polymorphism in an Iranian Population
F Sepahvand, P Rahimi-Moghaddam, M Shafiei, SM Ghaffari, M Rostam-Shirazi, M Mahmoudian |
Journal of Toxicology and Environmental Health, Part A | 2007 |
Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
ET Elkiran, N Mar, B Aygen, F Gursu, A Karaoglu, S Koca |
BMC Cancer | 2007 |
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
S Parra, C Alonso-Villaverde, B Coll, N Ferré, J Marsillach, G Aragonès, M Mackness, B Mackness, L Masana, J Joven, J Camps |
Atherosclerosis | 2007 |
Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis
M Aslan, M Horoz, Y Nazligul, C Bolukbas, FF Bolukbas, S Selek, N Aksoy, O Erel |
International Journal of Clinical Practice | 2007 |
Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients
N Angayarkanni, S Barathi, T Seethalakshmi, R Punitham, R Sivaramakrishna, G Suganeswari, S Tarun |
Eye | 2007 |
Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans
NS Kim, K Kang, MH Cha, BJ Kang, J Moon, BK Kang, BC Yu, YS Kim, SM Choi, OS Bang |
Biochemical and Biophysical Research Communications | 2007 |
Oxidative stress and systemic inflammation in patients with sleep apnea: Role of obesity
L LAVIE, A VISHNEVSKY, P LAVIE |
Sleep and Biological Rhythms | 2007 |
Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers
M Gur, A Yildiz, R Demirbag, R Yilmaz, M Aslan, I Ozdogru, O Erel |
Coronary Artery Disease | 2007 |
HIGH-DOSE TAURINE SUPPLEMENTATION INCREASES SERUM PARAOXONASE AND ARYLESTERASE ACTIVITIES IN EXPERIMENTAL HYPOTHYROIDISM
M Dirican, S Taş, E Sarandöl |
Clinical and Experimental Pharmacology and Physiology | 2007 |
Paraoxonase Phenotype Distribution in a Healthy Iranian Population
F Sepahvand, M Shafiei, SM Ghaffari, P Rahimi-Moghaddam, M Mahmoudian |
Basic & Clinical Pharmacology & Toxicology | 2007 |
Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol
SC Bergheanu, AV Tol, GM Dallinga-Thie, A Liem, PH Dunselman, JG van der Bom, JW Jukema |
Current Medical Research and Opinion | 2007 |
Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: A role for small, dense high-density lipoproteins
JM Arbonés-Mainar, MA Navarro, R Carnicer, N Guillén, JC Surra, S Acín, MA Guzmán, AJ Sarría, C Arnal, MP Aguilera, A Jiménez, G Beltrán, M Uceda, J Osada |
Atherosclerosis | 2007 |
Synergistic Effects between Q192R Polymorphism of Paraoxonase 1 Gene and Some Conventional Risk Factors in Premature Coronary Artery Disease
A Balcerzyk, I Zak, J Krauze |
Archives of Medical Research | 2007 |
Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation
M Shiner, B Fuhrman, M Aviram |
Atherosclerosis | 2007 |
Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: A stimulatory role for d-glucose
T Hayek, M Kaplan, R Kerry, M Aviram |
Atherosclerosis | 2007 |
The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase
A Kassai, L Illyés, HZ Mirdamadi, I Seres, T Kalmár, M Audikovszky, G Paragh |
Clinical Biochemistry | 2007 |
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
G Baskol, M Baskol, D Kocer |
Clinical Biochemistry | 2007 |
Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics
N Chilukuri, C Luo, B Doctor, A Saxena, D Maxwell |
Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics | 2007 |
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
A Sarandol, S Kirli, C Akkaya, N Ocak, E Eroz, E Sarandol |
Journal of Psychopharmacology (Oxford, England) | 2007 |
Polymorphisms and Vascular Cognitive Impairment After Ischemic Stroke
L Baum, X Chen, WS Cheung, CK Cheung, LW Cheung, KF Chiu, HM Wen, P Poon, KS Woo, HK Ng, KS Wong |
Journal of Geriatric Psychiatry and Neurology | 2007 |
Arylesterase Activity and Antioxidant Status Depend on PON1-Q192R and PON1-L55M Polymorphisms in Subjects with Increased Risk of Cardiovascular Disease Consuming Walnut-Enriched Meat
M Nus, F Frances, J Librelotto, A Canales, D Corella, JM Sánchez-Montero, FJ Sánchez-Muniz |
The Journal of nutrition | 2007 |
Age-Related Paraoxonase Activity Changes in Turkish Population
E Saruhan, A Olgun, K Ozturk, S Akman, MK Erbil |
Annals of the New York Academy of Sciences | 2007 |
Study of the Relationship between Gene Polymorphisms of Paraoxonase 2 and Stroke in a Chinese Population
HW Xu, N Yuan, Z Zhao, L Zhang, J Xia, KM Zeng, B Xiao, XS Yang, BS Tang |
Cerebrovascular Diseases | 2007 |
Accuracy and Biological Variation of Human Serum Paraoxonase 1 Activity and Polymorphism (Q192R) by Kinetic Enzyme Assay
RW Browne, ST Koury, S Marion, G Wilding, P Muti, M Trevisan |
Clinical chemistry | 2007 |
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding |
2007 | |
Low ethanol intake prevents salt-induced hypertension in WKY rats
S Vasdev, V Gill, S Parai, V Gadag |
Molecular and Cellular Biochemistry | 2006 |
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
A Kontush, MJ Chapman |
Pharmacological reviews | 2006 |
Time-dependent modulation of rat serum paraoxonase 1 activity by fasting
E Thomàs-Moyà, A Nadal-Casellas, M Gianotti, I Lladó, AM Proenza |
Pflügers Archiv - European Journal of Physiology | 2006 |
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection
S Bellosta, M Gomaraschi, M Canavesi, G Rossoni, M Monetti, G Franceschini, L Calabresi |
FEBS Letters | 2006 |
HDL inflammation and atherosclerosis: current and future perspectives
T Sampietro, F Bigazzi, M Puntoni, A Bionda |
Future Cardiology | 2006 |
Modified HDL: Biological and physiopathological consequences
GD Norata, A Pirillo, AL Catapano |
Nutrition, Metabolism and Cardiovascular Diseases | 2006 |
Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits
S Hong, S Zhao, Z Wu |
Journal of Cardiovascular Pharmacology | 2006 |
Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women
FF Verit, H Celik, P Yazgan, O Erel, I Geyikli |
Archives of Gynecology and Obstetrics | 2006 |
Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position
SD Nguyen, DE Sok |
Biochimica et Biophysica Acta (BBA) - Biomembranes | 2006 |
Hyperbaric oxygen: a new drug in myocardial revascularization and protection?
JZ Yogaratnam, G Laden, LA Madden, AM Seymour, L Guvendik, M Cowen, J Greenman, A Cale, S Griffin |
Cardiovascular Revascularization Medicine | 2006 |
A long and winding road: defining the biological role and clinical importance of paraoxonases
RW James |
Clinical Chemistry and Laboratory Medicine | 2006 |
Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease
M Granér, RW James, J Kahri, MS Nieminen, M Syvänne, MR Taskinen |
Journal of the American College of Cardiology | 2006 |
Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects
S Beer, X Moren, J Ruiz, RW James |
Nutrition, Metabolism and Cardiovascular Diseases | 2006 |
Paraoxonase and arylesterase activities in coronary artery disease
M Gur, M Aslan, A Yildiz, R Demirbag, R Yilmaz, S Selek, O Erel, I Ozdogru |
European Journal of Clinical Investigation | 2006 |
Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population
Q Huang, YH Liu, QD Yang, B Xiao, L Ge, N Zhang, J Xia, L Zhang, ZJ Liu |
Neurological Research | 2006 |
Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease
R Sanchez, E Levy, E Seidman, D Amre, F Costea, D Sinnett |
Gut | 2006 |
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms
S Vasdev, V Gill, PK Singal |
Vascular Health and Risk Management | 2006 |
Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants
S Vasdev, VD Gill, PK Singal |
Experimental and clinical cardiology | 2006 |
A new method for the determination of arylesterase activity in human serum using simulated body fluid
M Nus, FJ Sánchez-Muniz, JM Sánchez-Montero |
Atherosclerosis | 2006 |
Sobre los genes paraoxonasa-1 y SR-B1, y su importancia en la aterosclerosis
FR Esparragón, YH Trujillo, AM Reyes, EH Ortega, A Medina, JC Pérez |
Revista Española de Cardiología | 2006 |
Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: Possible role for paraoxonase-1 triacylglycerol lipase-like activity
B Fuhrman, N Volkova, M Aviram |
Nutrition | 2006 |
HDL dysfunction in obstructive sleep apnea
KC Tan, WS Chow, JC Lam, B Lam, WK Wong, S Tam, MS Ip |
Atherosclerosis | 2006 |
From Oxidative Stress to Cardiovascular Risk in Obstructive Sleep Apnoea. Vom oxidativen Stress zum kardiovaskularen Risiko bei obstruktiver Schlafapnoe
L Lavie |
Somnologie | 2006 |
A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity
M Shiner, B Fuhrman, M Aviram |
Biochemical and Biophysical Research Communications | 2006 |
Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetes
M Rosenblat, R Karry, M Aviram |
Atherosclerosis | 2006 |
S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity
O Rozenberg, M Aviram |
Biochemical and Biophysical Research Communications | 2006 |
Effects of Intranasal Estradiol Treatment on Serum Paraoxonase and Lipids in Healthy, Postmenopausal Women
IV Fenkci, M Serteser, S Fenkci, AM Akyol |
Gynecologic and Obstetric Investigation | 2006 |
Serum Paraoxonase 1 Activity and Lipid Peroxidation Levels in Patients with Age-Related Macular Degeneration
G Baskol, S Karakucuk, AO Oner, M Baskol, D Kocer, E Mirza, R Saraymen, M İstdal |
Ophthalmologica | 2006 |
Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder
A Sarandol, E Sarandol, SS Eker, EU Karaagac, BZ Hizli, M Dirican, S Kirli |
Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2006 |
Paraoxonase 1 (PON1) and its relationship to lipid variables, age and gender in healthy volunteers
K Sumegová, P Blažíček, B Fuhrman, I Waczulíková, Z Ďuračková |
Biologia | 2006 |
Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk
L Baum, HK Ng, KS Woo, B Tomlinson, TH Rainer, X Chen, WS Cheung, DK Chan, GN Thomas, CS Tong, KS Wong |
Clinical Biochemistry | 2006 |
Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease
Z Serdar, K Aslan, M Dirican, E Sarandöl, D Yeşilbursa, A Serdar |
Clinical Biochemistry | 2006 |
Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress
MS Calla, SM Lynch |
Archives of Biochemistry and Biophysics | 2006 |
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice
CJ Ng, SY Hama, N Bourquard, M Navab, ST Reddy |
Molecular Genetics and Metabolism | 2006 |
HDL: The ‘new’ target of cardiovascular medicine
T Sampietro, F Bigazzi, BD Pino, M Puntoni, A Bionda |
International Journal of Cardiology | 2006 |
Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in Atherosclerosis
FR Esparragón, YH Trujillo, AM Reyes, EH Ortega, A Medina, JC Pérez |
Revista Española de Cardiología (English Edition) | 2006 |
Influence of chronic exercise on red cell antioxidant defense, plasma malondialdehyde and total antioxidant capacity in hypercholesterolemic rabbits
M Alipour, M Mohammadi, N Zarghami, N Ahmadiasl |
Journal of sports science & medicine | 2006 |
The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux
M Rosenblat, L Gaidukov, O Khersonsky, J Vaya, R Oren, DS Tawfik, M Aviram |
The Journal of biological chemistry | 2006 |
Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides
T Kriska, GK Marathe, JC Schmidt, TM McIntyre, AW Girotti |
The Journal of biological chemistry | 2006 |
The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats
E Thomàs-Moyà, M Gianotti, AM Proenza, I Lladó |
Journal of lipid research | 2006 |
Isolation and characterization of human apolipoprotein M-containing lipoproteins
C Christoffersen, LB Nielsen, O Axler, A Andersson, AH Johnsen, B Dahlbäck |
Journal of lipid research | 2006 |
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease
CS Carlson, PJ Heagerty, TS Hatsukami, RJ Richter, J Ranchalis, J Lewis, TJ Bacus, LA McKinstry, GD Schellenberg, M Rieder, D Nickerson, CE Furlong, A Chait, GP Jarvik |
Journal of lipid research | 2006 |
Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure
RO Browne, LB Moyal-Segal, D Zumsteg, Y David, O Kofman, A Berger, H Soreq, A Friedman |
The FASEB Journal | 2006 |
Effects of caloric restriction and gender on rat serum paraoxonase 1 activity
E Thomàs-Moyà, M Gianotti, I Lladó, AM Proenza |
The Journal of Nutritional Biochemistry | 2006 |
Dyslipidemia and inflammation: an evolutionary conserved mechanism
E Esteve, W Ricart, JM Fernández-Real |
Clinical Nutrition | 2005 |
Paraoxonase 1 status in the Thai population
W Phuntuwate, C Suthisisang, B Koanantakul, MI Mackness, B Mackness |
Journal of Human Genetics | 2005 |
Effects of Surgical Menopause and Estrogen Replacement Therapy on Serum Paraoxonase Activity and Plasma Malondialdehyde Concentration
S Kumru, S Aydin, A Aras, MF Gursu, F Gulcu |
Gynecologic and Obstetric Investigation | 2005 |
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats
K Trudel, D Sinnett, RW James, E Delvin, D Amre, E Seidman, E Levy |
Journal of Cellular Biochemistry | 2005 |
Paraoxonase 1 (PON1) is present in postprandial chylomicrons
B Fuhrman, N Volkova, M Aviram |
Atherosclerosis | 2005 |
Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice
O Rozenberg, DM Shih, M Aviram |
Atherosclerosis | 2005 |
The cardiovascular protective effect of red wine
AC Cordova, LS Jackson, DW Berke-Schlessel, BE Sumpio |
Journal of the American College of Surgeons | 2005 |
Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities
B Bryk, L BenMoyal-Segal, E Podoly, O Livnah, A Eisenkraft, S Luria, A Cohen, Y Yehezkelli, A Hourvitz, H Soreq |
Journal of Neurochemistry | 2005 |
Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene
K Ota, T Suehiro, K Arii, Y Ikeda, Y Kumon, F Osaki, K Hashimoto |
Metabolism | 2005 |
Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon
KA OʼLeary, RJ Edwards, MM Town, AR Boobis |
Pharmacogenetics and Genomics | 2005 |
Oxidative inactivation of paraoxonase—implications in diabetes mellitus and atherosclerosis
SA Karabina, AN Lehner, E Frank, S Parthasarathy, N Santanam |
Biochimica et Biophysica Acta (BBA) - General Subjects | 2005 |
Bovine Paraoxonase 1 Activities in Serum and Distribution in Lipoproteins
T MIYAMOTO, Y TAKAHASHI, T OOHASHI, K SATO, S OIKAWA |
Journal of Veterinary Medical Science | 2005 |
Sleep-Disordered Breathing and Cerebrovascular Disease: A Mechanistic Approach
L Lavie |
Neurologic Clinics | 2005 |
Intravenöse Sauerstofftherapie erhöht die Aktivität des antioxidativen und antiatherogenetischen Enzyms Paraoxonase-1 im Serum
S Kopprasch, FJ Kreutzer, V Nowak, J Graessler |
Forschende Komplementärmedizin und Klassische Naturheilkunde / Research in Complementary and Classical Natural Medicine | 2005 |
The Effect of Hormone Replacement Therapy on Oxidized Low Density Lipoprotein Levels and Paraoxonase Activity in Postmenopausal Women
A Topçuoglu, H Uzun, S Aydin, N Kahraman, S Vehid, G Zeybek, D Topçuoglu |
The Tohoku Journal of Experimental Medicine | 2005 |
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia
TM Himbergen, LJ Tits, HA Voorbij, J Graaf, AF Stalenhoef, M Roest |
Journal of Internal Medicine | 2005 |
Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats
S Tas, E Sarandol, S Ziyanok, K Aslan, M Dirican |
Nutrition Research | 2005 |
Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis
G Baskol, H Demir, M Baskol, E Kilic, F Ates, D Kocer, S Muhtaroglu |
Clinical Biochemistry | 2005 |
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov, JF Teiber, A Speelman, Y Osawa, R Sunahara, BN la Du |
Journal of lipid research | 2005 |
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
DM Shih, HR Kast-Woelbern, J Wong, YR Xia, PA Edwards, AJ Lusis |
Journal of lipid research | 2005 |
Atherosclerosis: Diet and Drugs
A von Eckardstein |
2005 | |
Structure−Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase
O Khersonsky, DS Tawfik |
Biochemistry | 2005 |
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
M Rosenblat, J Vaya, D Shih, M Aviram |
Atherosclerosis | 2004 |
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram, M Rosenblat |
Free radical biology & medicine | 2004 |
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities
RS Rosenson |
Atherosclerosis | 2004 |
Low Serum α-Tocopherol Concentrations in Subjects With Various Coronary Risk Factors
K Miwa, S Okinaga, M Fujita |
Circulation Journal | 2004 |
Omapatrilat Decreased Macrophage Oxidative Status and Atherosclerosis Progression in Atherosclerotic Apolipoprotein E-Deficient Mice
T Hayek, S Hamoud, S Keidar, E Pavlotzky, R Coleman, M Aviram, M Kaplan |
Journal of Cardiovascular Pharmacology | 2004 |
Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid
T Kujiraoka, H Hattori, M Ito, MN Nanjee, M Ishihara, M Nagano, T Iwasaki, CJ Cooke, WL Olszewski, IP Stepanova, T Egashira, NE Miller |
Atherosclerosis | 2004 |
Q192R polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a biracial community
SR Srinivasan, S Li, W Chen, R Tang, MG Bond, E Boerwinkle, GS Berenson |
Atherosclerosis | 2004 |
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres, G Paragh, E Deschene, T Fulop, A Khalil |
Experimental Gerontology | 2004 |
Paraoxonase 1 activity, concentration and genotype in cardiovascular disease
M Mackness, P Durrington, B Mackness |
Current Opinion in Lipidology | 2004 |
Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction
N Martinelli, D Girelli, O Olivieri, C Stranieri, E Trabetti, F Pizzolo, S Friso, I Tenuti, S Cheng, MA Grow, PF Pignatti, R Corrocher |
European Journal of Clinical Investigation | 2004 |
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients
M Boemi, C Sirolla, R Testa, S Cenerelli, P Fumelli, RW James |
Diabetic Medicine | 2004 |
Paraoxonase, a cardioprotective enzyme: continuing issues
GS Getz, CA Reardon |
Current Opinion in Lipidology | 2004 |
Polygonatum Rhizoma Affects Antioxidant Defense Systems Without Changing mRNA Expression in Diet-Induced Hypercholesterolemic Rabbits
SM Jeon, MK Lee, YB Park, HM Park, MS Choi |
Journal of Medicinal Food | 2004 |
Serum paraoxonase activity is decreased in the active stage of Behçet's disease
S Karakucuk, G Baskol, AO Oner, M Baskol, E Mirza, M Ustdal |
The British journal of ophthalmology | 2004 |
Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study
EH Sklan, A Lowenthal, M Korner, Y Ritov, DM Landers, T Rankinen, C Bouchard, AS Leon, T Rice, DC Rao, JH Wilmore, JS Skinner, H Soreq |
Proceedings of the National Academy of Sciences | 2004 |
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia
ML Liu, RW James, K Ylitalo, MR Taskinen |
Nutrition, Metabolism and Cardiovascular Diseases | 2004 |
Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation
E Sarand�l, S Ta?, M Dirican, Z Serdar |
Cell Biochemistry and Function | 2004 |
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
M Aviram, M Rosenblat, D Gaitini, S Nitecki, A Hoffman, L Dornfeld, N Volkova, D Presser, J Attias, H Liker, T Hayek |
Clinical Nutrition | 2004 |
Acetylcholine esterase protects LDL against oxidation
B Fuhrman, A Partoush, M Aviram |
Biochemical and Biophysical Research Communications | 2004 |
Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages
M Shiner, B Fuhrman, M Aviram |
Free radical biology & medicine | 2004 |
Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia
E Sarandöl, Ö aŞafak, M Dirican, G Uncu |
Clinical Biochemistry | 2004 |
Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia
FD Brites, J Verona, LE Schreier, JC Fruchart, GR Castro, RL Wikinski |
Archives of Medical Research | 2004 |
A fluorogenic substrate for detection of organophosphatase activity
S Soukharev, DJ Hammond |
Analytical Biochemistry | 2004 |
Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris
M Sharifi, W Fares, I Abdel-Karim, JM Koch, J Sopko, D Adler |
The American Journal of Cardiology | 2004 |
Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus
M Murata, T Maruyama, Y Suzuki, T Saruta, Y Ikeda |
Diabetic Medicine | 2004 |
Comprehensive Handbook of Alcohol Related Pathology
J Sastre, JB Miñana, FV Pallardó, J Viña |
Comprehensive Handbook of Alcohol Related Pathology | 2004 |
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat |
Revista Española de Cardiología (English Edition) | 2004 |
Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat |
Revista Española de Cardiología | 2004 |
PON1 M/L55 mutation protects high-risk patients against coronary artery disease
SA Oliveira, AP Mansur, CC Ribeiro, JA Ramires, JM Annichino-Bizzacchi |
International Journal of Cardiology | 2004 |
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
SD Nguyen, DE Sok |
Journal of lipid research | 2004 |
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia
TM van Himbergen, M Roest, J Graaf, EH Jansen, H Hattori, JJ Kastelein, HA Voorbij, AF Stalenhoef, LJ van Tits |
Journal of lipid research | 2004 |
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
JF Teiber, DI Draganov, BN la Du |
Journal of lipid research | 2004 |
Oxidative stress in white coat hypertension; role of paraoxonase
H Uzun, Y Karter, S Aydin, A Çurgunlu, G Şimşek, R Yücel, S Vehiyd, N Ertürk, A Kutlu, A Benian, A Yaldiran, E Öztürk, S Erdine |
Journal of Human Hypertension | 2004 |
Association of paraoxonase-1 M55L genotype and alcohol consumption with coronary atherosclerosis: the Helsinki Sudden Death Study
R Rontu, T Lehtimki, E Ilveskoski, J Mikkelsson, O Kajander, S Goebeler, M Perola, A Penttil, PJ Karhunen |
Pharmacogenetics | 2004 |
Association of Paraoxonase 1 Polymorphism With Beta-Cell Function: A Case of Molecular Heterosis
KC Chiu, LM Chuang, A Chu, J Lu, J Hu, S Fernando |
Pancreas | 2004 |
Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen
D Ganten, K Ruckpaul, A Ruiz-Torres |
2004 | |
The Role of Paraoxonase 1 Activity in Cardiovascular Disease: Potential for Therapeutic Intervention
MI Mackness, PN Durrington, B Mackness |
American Journal Cardiovascular Drugs | 2004 |
Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide‐induced Parkinson's disease
L Benmoyal-Segal, T Vander, S Shifman, B Bryk, R Ebstein, EL Marcus, J Stessman, A Darvasi, Y Herishanu, A Friedman, H Soreq |
The FASEB Journal | 2004 |
Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism
C Gouédard, R Barouki, Y Morel |
Molecular and cellular biology | 2004 |
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs |
Chemical Reviews | 2003 |
Opposite Regulation of the Human Paraoxonase-1 Gene PON-1 by Fenofibrate and Statins
C Gouédard, N Koum-Besson, R Barouki, Y Morel |
Molecular pharmacology | 2003 |
Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice
S Keidar, T Hayek, M Kaplan, E Pavlotzky, S Hamoud, R Coleman, M Aviram |
Journal of Cardiovascular Pharmacology | 2003 |
RENAL RESEARCH INSTITUTE SYMPOSITUM: Characteristics and Effects of Inflammation in End-Stage Renal Disease
GA Kaysen, JP Eiserich |
Seminars in Dialysis | 2003 |
Coronary Artery Disease
Y Okura, K Hayashi, T Shingu, Y Kuga, S Nomura, G Kajiyama, Y Nakashima, K Saku |
Coronary Artery Disease | 2003 |
Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study
R Rontu, PJ Karhunen, E Ilveskoski, J Mikkelsson, O Kajander, M Perola, A Penttilä, AM Koivisto, T Lehtimäki |
Atherosclerosis | 2003 |
Expression of human paraoxonase (PON1) during development
TB Cole, RL Jampsa, BJ Walter, TL Arndt, RJ Richter, DM Shih, A Tward, AJ Lusis, RM Jack, LG Costa, CE Furlong |
Pharmacogenetics | 2003 |
Functional Genomics of the Paraoxonase (PON1) Polymorphisms: Effects on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism
LG Costa, TB Cole, GP Jarvik, CE Furlong |
Annual Review of Medicine | 2003 |
R/R Genotype of Human Paraoxonase(PON1) is More Protective against Lipoprotein Oxidation and Coronary Artery Disease in Japanese Subjects
K Kuremoto, Y Watanabe, H Ohmura, K Shimada, H Mokuno, H Daida |
Journal of Atherosclerosis and Thrombosis | 2003 |
Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization
SD Nguyen, DE Sok |
Biochemical Journal | 2003 |
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties
L Rodrigo, F Gil, AF Hernandez, O Lopez, A Pla |
Biochemical Journal | 2003 |
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
A Aharoni, L Gaidukov, S Yagur, L Toker, I Silman, DS Tawfik |
Proceedings of the National Academy of Sciences | 2003 |
Two cinnamate derivatives produce similar alteration in mRNA expression and activity of antioxidant enzymes in rats
MK Lee, EM Park, SH Bok, UJ Jung, JY Kim, YB Park, TL Huh, OS Kwon, MS Choi |
Journal of Biochemical and Molecular Toxicology | 2003 |
Cholesteryl ester oxidation products in atherosclerosis
N Leitinger |
Molecular Aspects of Medicine | 2003 |
Serum paraoxonase activity decreases in rheumatoid arthritis
N Tanimoto, Y Kumon, T Suehiro, S Ohkubo, Y Ikeda, K Nishiya, K Hashimoto |
Life Sciences | 2003 |
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6
Y Kumon, T Suehiro, Y Ikeda, K Hashimoto |
Life Sciences | 2003 |
Update on vascular disease in systemic lupus erythematosus
AH Kao, JM Sabatine, S Manzi |
Current Opinion in Rheumatology | 2003 |
PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease
E Azarsız, M Kayıkcıoǧlu, S Payzın, EY Sözmen |
International Journal of Cardiology | 2003 |
Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity
G Ferretti, T Bacchetti, E Marotti, G Curatola |
Metabolism | 2003 |
Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II
Kirsty S Robertson, Emma Hawe, George J Miller, Philippa J Talmud, Steve E Humphries, |
Biochimica et Biophysica Acta | 2003 |
Altered Gene Expression in Liver from a Murine Model of Hyperhomocysteinemia
K Robert, JF Chassé, D Santiard-Baron, C Vayssettes, A Chabli, J Aupetit, N Maeda, P Kamoun, J London, N Janel |
The Journal of biological chemistry | 2003 |
Increased influence of genetic variation on PON1 activity in neonates
J Chen, M Kumar, W Chan, G Berkowitz, JG Wetmur |
Environmental Health Perspectives | 2003 |
Oral Insulin Supplementation Attenuates Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
R Shamir, N Shehadeh, M Rosenblat, O Eshach-Adiv, R Coleman, M Kaplan, S Hamoud, S Lischinsky, T Hayek |
Arteriosclerosis, thrombosis, and vascular biology | 2003 |
Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome
M Sentí, M Tomás, M Fitó, T Weinbrenner, MI Covas, J Sala, R Masiá, J Marrugat |
The Journal of clinical endocrinology and metabolism | 2003 |
Paraoxonase gene polymorphisms, oxidative stress, and diseases
HL Li, DP Liu, CC Liang |
Journal of Molecular Medicine | 2003 |
Wiley Encyclopedia of Molecular Medicine
WT Morgan |
Wiley Encyclopedia of Molecular Medicine | 2002 |
Wine
A Klatsky |
Wine | 2002 |
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann, A Eckardstein |
Atherosclerosis | 2002 |
Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis
M Aviram, B Fuhrman |
Annals of the New York Academy of Sciences | 2002 |
Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice
M Rosenblat, R Coleman, M Aviram |
Atherosclerosis | 2002 |
Oxidized lipids as mediators of coronary heart disease
M Navab, SY Hama, ST Ready, CJ Ng, BJ van Lenten, H Laks, AM Fogelman |
Current Opinion in Lipidology | 2002 |
Influence of norbixin on plasma cholesterol-associated lipoproteins, plasma arylesterase/paraoxonase activity and hepatic lipid peroxidation of Swiss mice on a high fat diet
AA Santos, MV Silva, LT Guerreiro, MV Alves, VL Bastos, JC Bastos, K Kovary |
Food Chemistry | 2002 |
The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs
A Gnasso, C Motti, C Irace, ID Gennaro, A Pujia, E Leto, M Ciamei, A Crivaro, S Bernardini, G Federici, C Cortese |
Atherosclerosis | 2002 |
Kinetics of HDL Cholesterol and Paraoxonase Activity in Moderate Alcohol Consumers
A Sierksma, MS van der Gaag, A Tol, RW James, HF Hendriks |
Alcoholism: Clinical & Experimental Research | 2002 |
Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium(III) chloride
RY Cheng, WG Alvord, D Powell, KS Kasprzak, LM Anderson |
Reproductive Toxicology | 2002 |
The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments
I Pinchuk, D Lichtenberg |
Progress in Lipid Research | 2002 |
Paraoxonase 1 Activity: A New Vascular Marker of Dementia?
TF Dantoine, J Debord, L Merle, H Lacroix-Ramiandrisoa, L Bourzeix, JP Charmes |
Annals of the New York Academy of Sciences | 2002 |
Multiple Substrates for Paraoxonase-1 during Oxidation of Phosphatidylcholine by Peroxynitrite
Z Ahmed, A Ravandi, GF Maguire, A Emili, D Draganov, BN la Du, A Kuksis, PW Connelly |
Biochemical and Biophysical Research Communications | 2002 |
Detection of oxidized high-density lipoprotein
T Matsunaga, I Koyama, S Hokari, T Komoda |
Journal of Chromatography B | 2002 |
Higher antioxidant defences in plasma and low density lipoproteins from rugby players
P Evelson, G Gambino, M Travacio, G Jaita, J Verona, C Maroncelli, R Wikinski, S Llesuy, F Brites |
European Journal of Clinical Investigation | 2002 |
Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase
B Fuhrman, N Volkova, M Aviram |
Atherosclerosis | 2002 |
Paraoxonase 1 Overexpression in Mice and Its Effect on High-Density Lipoproteins
MN Oda, JK Bielicki, TT Ho, T Berger, EM Rubin, TM Forte |
Biochemical and Biophysical Research Communications | 2002 |
HDL or not HDL, that is the question
RW James |
European Journal of Clinical Investigation | 2002 |
Detoxification of Oxidized LDL by Transferring Its Oxidation Product(s) to Lecithin:Cholesterol Acyltransferase
ZH Howlader, S Kamiyama, H Shirakawa, Y Murakami, M Ito, M Komai, K Muramoto, Y Furukawa |
Biochemical and Biophysical Research Communications | 2002 |
Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats
MK Lee, SH Bok, TS Jeong, SS Moon, SE Lee, YB Park, MS Choi |
Bioorganic & Medicinal Chemistry | 2002 |
Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells
Y Kumon, Y Nakauchi, T Suehiro, T Shiinoki, N Tanimoto, M Inoue, T Nakamura, K Hashimoto, JD Sipe |
Amyloid | 2002 |
Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure
B Fuhrman, N Volkova, M Kaplan, D Presser, J Attias, T Hayek, M Aviram |
Nutrition | 2002 |
Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes
B Fuhrman, L Koren, N Volkova, S Keidar, T Hayek, M Aviram |
Atherosclerosis | 2002 |
Preservation of Paraoxonase Activity by Wine Flavonoids
B Fuhrman, M Aviram |
Annals of the New York Academy of Sciences | 2002 |
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease
N Ferré, M Tous, A Paul, A Zamora, JJ Vendrell, A Bardajı́, J Camps, C Richart, J Joven |
Clinical Biochemistry | 2002 |
Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages
S Keidar, R Heinrich, M Kaplan, M Aviram |
Journal of Renin-Angiotensin-Aldosterone System | 2002 |
Paraoxonase and coronary heart disease
MI Mackness, B Mackness, PN Durrington |
Atherosclerosis Supplements | 2002 |
Effect of Alcohol on Lipids and Lipoproteins in Relation to Atherosclerosis
ML Hannuksela, MK Liisanantti, MJ Savolainen |
Critical Reviews in Clinical Laboratory Sciences | 2002 |
Platelet-activating Factor Acetylhydrolase, and Not Paraoxonase-1, Is the Oxidized Phospholipid Hydrolase of High Density Lipoprotein Particles
GK Marathe, GA Zimmerman, TM McIntyre |
The Journal of biological chemistry | 2002 |
Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias
Z Janka, A Juhász, Á Rimanóczy, K Boda, J Márki-Zay, J Kálmán |
Molecular Psychiatry | 2002 |
Further evidence for an association of the Paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
A Carmine, S Buervenich, O Sydow, M Anvret, L Olson |
Movement disorders : official journal of the Movement Disorder Society | 2002 |
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
A Tward, YR Xia, XP Wang, YS Shi, C Park, LW Castellani, AJ Lusis, DM Shih |
Circulation | 2002 |
Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB
V Tsimihodimos, SA Karabina, AP Tambaki, E Bairaktari, JA Goudevenos, MJ Chapman, M Elisaf, AD Tselepis |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity
GP Jarvik, NT Tsai, LA McKinstry, R Wani, VH Brophy, RJ Richter, GD Schellenberg, PJ Heagerty, TS Hatsukami, CE Furlong |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Paraoxonase (PON1) in Health and Disease
LG Costa, CE Furlong |
2002 | |
Grape Seed Proanthocyanidins Prevent Plasma Postprandial Oxidative Stress in Humans
F Natella, F Belelli, V Gentili, F Ursini, C Scaccini |
Journal of Agricultural and Food Chemistry | 2002 |
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
E Boisfer, D Stengel, D Pastier, PM Laplaud, N Dousset, E Ninio, AD Kalopissis |
Journal of lipid research | 2002 |
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
TM Forte, G Subbanagounder, JA Berliner, PJ Blanche, AO Clermont, Z Jia, MN Oda, RM Krauss, JK Bielicki |
Journal of lipid research | 2002 |
Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte
L Perrin-Cocon, F Coutant, S Agaugué, S Deforges, P André, V Lotteau |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Oxidized LDL and HDL: antagonists in atherothrombosis
A Mertens, P Holvoet |
The FASEB Journal | 2001 |
Handbook of Antioxidants
K Meissner, W Siems, O Sommerburg, M Leichsenring |
Handbook of Antioxidants | 2001 |
Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2
W Pruzanski, E Stefanski, J Kopilov, A Kuksis |
Laboratory Investigation | 2001 |
Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure
JK Bielicki, LJ Knoff, DL Tribble, TM Forte |
Atherosclerosis | 2001 |
Polymorphisms in the human paraoxonase (PON1) promoter
VH Brophy, MD Hastings, JB Clendenning, RJ Richter, GP Jarvik, CE Furlong |
Pharmacogenetics | 2001 |
Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R
CE Watson, DI Draganov, SS Billecke, CL Bisgaier, BN la Du |
Pharmacogenetics | 2001 |
Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression
VH Brophy, RL Jampsa, JB Clendenning, LA McKinstry, GP Jarvik, CE Furlong |
The American Journal of Human Genetics | 2001 |
Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects
O Raveh, I Pinchuk, M Fainaru, D Lichtenberg |
Free radical biology & medicine | 2001 |
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study
M Sentí |
Atherosclerosis | 2001 |
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
T Quaschning, V Krane, T Metzger, C Wanner |
American Journal of Kidney Diseases | 2001 |
Biotransformation of organophosphorus compounds
M Jokanović |
Toxicology | 2001 |
Flavonoids protect LDL from oxidation and attenuate atherosclerosis
B Fuhrman, M Aviram |
Current Opinion in Lipidology | 2001 |
Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. implications for its physiological role
L Rodrigo, AF Hernández, JJ López-Caballero, F Gil, A Pla |
Chemico-Biological Interactions | 2001 |
Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans
C Matsumoto |
Neuroscience Letters | 2001 |
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
PP Toth |
Disease-a-Month | 2001 |
Alcohol in Health and Disease: A Review
M Hannuksela, M Savolainen |
Alcohol in Health and Disease | 2001 |
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
M Navab, SY Hama, GP Hough, G Subbanagounder, ST Reddy, AM Fogelman |
Journal of lipid research | 2001 |
Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor
Z Ahmed, A Ravandi, GF Maguire, A Emili, D Draganov, BN la Du, A Kuksis, PW Connelly |
The Journal of biological chemistry | 2001 |
Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism
S Deakin, I Leviev, M Gomaraschi, L Calabresi, G Franceschini, RW James |
The Journal of biological chemistry | 2001 |
Pomegranate Juice Supplementation to Atherosclerotic Mice Reduces Macrophage Lipid Peroxidation, Cellular Cholesterol Accumulation and Development of Atherosclerosis
M Kaplan, T Hayek, A Raz, R Coleman, L Dornfeld, J Vaya, M Aviram |
The Journal of nutrition | 2001 |
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
PK Shah, S Kaul, J Nilsson, B Cercek |
Circulation | 2001 |
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II
PK Shah, S Kaul, J Nilsson, B Cercek |
Circulation | 2001 |
Paraoxonase and Atherosclerosis
PN Durrington, B Mackness, MI Mackness |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
M Navab, JA Berliner, G Subbanagounder, S Hama, AJ Lusis, LW Castellani, S Reddy, D Shih, W Shi, AD Watson, BJ Lenten, D Vora, AM Fogelman |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes
AJ Wallace, WH Sutherland, JI Mann, SM Williams |
European Journal of Clinical Nutrition | 2001 |
Is the Oxidation of High-Density Lipoprotein Lipids Different Than the Oxidation of Low-Density Lipoprotein Lipids? ,
MJ Thomas, Q Chen, M Zabalawi, R Anderson, M Wilson, R Weinberg, MG Sorci-Thomas, LL Rudel |
Biochemistry | 2001 |
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
I Leviev, S Deakin, RW James |
Journal of lipid research | 2001 |
Baculovirus-mediated expression and purification of human serum paraoxonase 1A
RJ Brushia, TM Forte, MN Oda, BN Du, JK Bielicki |
Journal of lipid research | 2001 |
Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease
PK Shah |
Expert Opinion on Investigational Drugs | 2000 |
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype
VH Brophy, GP Jarvik, RJ Richter, LS Rozek, GD Schellenberg, CE Furlong |
Pharmacogenetics | 2000 |
The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart disease
A Gardemann, M Philipp, K Heß, N Katz, H Tillmanns, W Haberbosch |
Atherosclerosis | 2000 |
Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases
Y Imai, H Morita, H Kurihara, T Sugiyama, N Kato, A Ebihara, C Hamada, Y Kurihara, T Shindo, Y Oh-hashi, Y Yazaki |
Atherosclerosis | 2000 |
A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression
T Suehiro, T Nakamura, M Inoue, T Shiinoki, Y Ikeda, Y Kumon, M Shindo, H Tanaka, K Hashimoto |
Atherosclerosis | 2000 |
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
M Navab, SY Hama, CJ Cooke, GM Anantharamaiah, M Chaddha, L Jin, G Subbanagounder, KF Faull, ST Reddy, NE Miller, AM Fogelman |
Journal of lipid research | 2000 |
Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis
Y Frishberg, H Toledano, R Becker-Cohen, E Feigin, D Halle |
American Journal of Kidney Diseases | 2000 |
How high-density lipoprotein protects against the effects of lipid peroxidation
M I Mackness, P N Durrington, B Mackness |
Current Opinion in Lipidology | 2000 |
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
DM Shih, YR Xia, XP Wang, E Miller, LW Castellani, G Subbanagounder, H Cheroutre, KF Faull, JA Berliner, JL Witztum, AJ Lusis |
The Journal of biological chemistry | 2000 |
Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation
DI Draganov, PL Stetson, CE Watson, SS Billecke, BN la Du |
The Journal of biological chemistry | 2000 |
Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans
H Wiseman, JD O'Reilly, H Adlercreutz, AI Mallet, EA Bowey, IR Rowland, TA Sanders |
The American journal of clinical nutrition | 2000 |
Dietary Fat Modulates Serum Paraoxonase 1 Activity in Rats
BJ Kudchodkar, AG Lacko, L Dory, TV Fungwe |
The Journal of nutrition | 2000 |
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice
M Aviram, L Dornfeld, M Rosenblat, N Volkova, M Kaplan, R Coleman, T Hayek, D Presser, B Fuhrman |
The American journal of clinical nutrition | 2000 |
Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease
RW James, I Leviev, A Righetti |
Circulation | 2000 |
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions: PON1 Esterase and Peroxidase-Like Activities
M Aviram, E Hardak, J Vaya, S Mahmood, S Milo, A Hoffman, S Billicke, D Draganov, M Rosenblat |
Circulation | 2000 |
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
I Leviev, RW James |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Infection and Inflammation Induce LDL Oxidation In Vivo
RA Memon, I Staprans, M Noor, WM Holleran, Y Uchida, AH Moser, KR Feingold, C Grunfeld |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Hyperbaric Oxygen Reduces the Progression and Accelerates the Regression of Atherosclerosis in Rabbits
BJ Kudchodkar, J Wilson, A Lacko, L Dory |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E–Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase: Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis
BD Geest, D Stengel, M Landeloos, M Lox, LL Gat, D Collen, P Holvoet, E Ninio |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Oxidized Cholesterol in the Diet Accelerates the Development of Atherosclerosis in LDL Receptor– and Apolipoprotein E–Deficient Mice
I Staprans, XM Pan, JH Rapp, C Grunfeld, KR Feingold |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients
M Tomás, M Sentí, F García-Faria, J Vila, A Torrents, M Covas, J Marrugat |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Impact of Antioxidants and HDL on Glycated LDL–Induced Generation of Fibrinolytic Regulators From Vascular Endothelial Cells
S Ren, GX Shen |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Cardiology for the primary care Physician
JS Alpert |
2000 | |
Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression
PW Baker, KA Rye, JR Gamble, MA Vadas, PJ Barter |
Journal of lipid research | 2000 |
Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins
W Pruzanski, E Stefanski, FC de Beer, MC de Beer, A Ravandi, A Kuksis |
Journal of lipid research | 2000 |
A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration
T Kujiraoka, T Oka, M Ishihara, T Egashira, T Fujioka, E Saito, S Saito, NE Miller, H Hattori |
Journal of lipid research | 2000 |
Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endothelium
HM Dansky, SA Charlton, CB Barlow, M Tamminen, JD Smith, JS Frank, JL Breslow |
Journal of Clinical Investigation | 1999 |
Remodelling of high density lipoproteins by plasma factors
KA Rye, MA Clay, PJ Barter |
Atherosclerosis | 1999 |
Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonase
M Kaplan, M Aviram |
Clinical Chemistry and Laboratory Medicine | 1999 |
The protective role of high-density lipoproteins in atherosclerosis
S Mingpeng, W Zongli |
Experimental Gerontology | 1999 |
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, J Delattre |
Clinical Chemistry and Laboratory Medicine | 1999 |
Atheroprotective mechanisms of HDL
O Stein, Y Stein |
Atherosclerosis | 1999 |
Paraoxonase Genes and Disease
RA Hegele |
Annals of Medicine | 1999 |
Macrophage Foam Cell Formation During Early Atherogenesis Is Determined by the Balance Between Pro-Oxidants and Anti-Oxidants in Arterial Cells and Blood Lipoproteins
M Aviram |
Antioxidants & Redox Signaling | 1999 |
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men
MS van der Gaag, A Tol, LM Scheek, RW James, R Urgert, G Schaafsma, HF Hendriks |
Atherosclerosis | 1999 |
Does paraoxonase play a role in susceptibility to cardiovascular disease?
M Aviram |
Molecular Medicine Today | 1999 |
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
M Aviram, M Rosenblat, S Billecke, J Erogul, R Sorenson, CL Bisgaier, RS Newton, BL Du |
Free radical biology & medicine | 1999 |
Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins
A Karakaya, S İbiş, T Kural, SK Köse, AE Karakaya |
Chemico-Biological Interactions | 1999 |
Isolation and complete covalent structure of liver microsomal paraoxonase
J Ozols |
Biochemical Journal | 1999 |
The role of oxidative stress in atherosclerosis: the hope and the hype
MS Runge |
Transactions of the American Clinical and Climatological Association | 1999 |
Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein
M Aviram, UM Kent, PF Hollenberg |
Atherosclerosis | 1999 |
On the physiological role(s) of the paraoxonases
BN la Du, M Aviram, S Billecke, M Navab, S Primo-Parmo, RC Sorenson, TJ Standiford |
Chemico-Biological Interactions | 1999 |
Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase
RC Sorenson, M Aviram, CL Bisgaier, S Billecke, C Hsu, BN la Du |
Chemico-Biological Interactions | 1999 |
Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity
RC Sorenson, CL Bisgaier, M Aviram, C Hsu, S Billecke, BN la Du |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for low- and high-density lipoproteins as estrogen carriers
QH Meng, A Höckerstedt, S Heinonen, K Wähälä, H Adlercreutz, MJ Tikkanen |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 1999 |
Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma
VS Subramanian, J Goyal, M Miwa, J Sugatami, M Akiyama, M Liu, PV Subbaiah |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 1999 |
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat
WH Sutherland, RJ Walker, SA de Jong, AM van Rij, V Phillips, HL Walker |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
JK Bielicki, TM Forte |
Journal of lipid research | 1999 |
Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
H Cao, A Girard-Globa, F Berthezene, P Moulin |
Journal of lipid research | 1999 |
High density associated enzymes: their role in vascular biology
M Navab, SY Hama, GP Hough, CC Hedrick, R Sorenson, BN la Du, JA Kobashigawa, GC Fonarow, JA Berliner, H Laks, AM Fogelman |
Current Opinion in Lipidology | 1998 |
Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses
PM Laplaud, T Dantoine, MJ Chapman |
Clinical Chemistry and Laboratory Medicine | 1998 |
An Assessment of the Scientific Basis for Attempting to Define the Dietary Reference Intake for Beta Carotene
GS Omenn |
Journal of the American Dietetic Association | 1998 |
Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities: Selective Action of Human Paraoxonase Allozymes Q and R
M Aviram, S Billecke, R Sorenson, C Bisgaier, R Newton, M Rosenblat, J Erogul, C Hsu, C Dunlop, BL Du |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Molecular and Cellular Effects of Nutrition on Disease Processes
GN Pierce, T Izumi, H Rupp, A Grynberg |
1998 | |
LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants
M Aviram, B Fuhrman |
Molecular and Cellular Biochemistry | 1998 |
Nitric Oxide
RA Schroeder, PC Kuo |
Anesthesia & Analgesia | 1995 |
Pharmacogenetics
BM Watson |
Anaesthesia | 1969 |